WO2021175029A1 - A novel form of metrafenone, a process for its preparation and use of the same - Google Patents
A novel form of metrafenone, a process for its preparation and use of the same Download PDFInfo
- Publication number
- WO2021175029A1 WO2021175029A1 PCT/CN2021/072802 CN2021072802W WO2021175029A1 WO 2021175029 A1 WO2021175029 A1 WO 2021175029A1 CN 2021072802 W CN2021072802 W CN 2021072802W WO 2021175029 A1 WO2021175029 A1 WO 2021175029A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- metrafenone
- crystalline modification
- crystalline
- solvent system
- composition
- Prior art date
Links
- AMSPWOYQQAWRRM-UHFFFAOYSA-N metrafenone Chemical compound COC1=CC=C(Br)C(C)=C1C(=O)C1=C(C)C=C(OC)C(OC)=C1OC AMSPWOYQQAWRRM-UHFFFAOYSA-N 0.000 title claims abstract description 180
- 239000005810 Metrafenone Substances 0.000 title claims abstract description 168
- 238000000034 method Methods 0.000 title claims abstract description 46
- 238000002360 preparation method Methods 0.000 title claims description 13
- 230000008569 process Effects 0.000 title description 6
- 239000000203 mixture Substances 0.000 claims abstract description 86
- 230000004048 modification Effects 0.000 claims abstract description 85
- 238000012986 modification Methods 0.000 claims abstract description 85
- 230000002538 fungal effect Effects 0.000 claims abstract description 11
- 206010061217 Infestation Diseases 0.000 claims abstract description 10
- 239000002904 solvent Substances 0.000 claims description 61
- 239000002689 soil Substances 0.000 claims description 31
- -1 colourants Substances 0.000 claims description 19
- 239000003795 chemical substances by application Substances 0.000 claims description 18
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 claims description 15
- 239000013078 crystal Substances 0.000 claims description 14
- 239000002270 dispersing agent Substances 0.000 claims description 13
- 239000007787 solid Substances 0.000 claims description 12
- 239000004546 suspension concentrate Substances 0.000 claims description 12
- 230000001747 exhibiting effect Effects 0.000 claims description 10
- 239000008187 granular material Substances 0.000 claims description 10
- BZLVMXJERCGZMT-UHFFFAOYSA-N Methyl tert-butyl ether Chemical compound COC(C)(C)C BZLVMXJERCGZMT-UHFFFAOYSA-N 0.000 claims description 9
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 9
- 150000002170 ethers Chemical class 0.000 claims description 9
- 230000011514 reflex Effects 0.000 claims description 9
- 239000002518 antifoaming agent Substances 0.000 claims description 8
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 7
- 239000000945 filler Substances 0.000 claims description 7
- 238000002329 infrared spectrum Methods 0.000 claims description 7
- 239000000843 powder Substances 0.000 claims description 7
- 239000008096 xylene Substances 0.000 claims description 7
- 238000000113 differential scanning calorimetry Methods 0.000 claims description 6
- 238000002844 melting Methods 0.000 claims description 6
- 230000008018 melting Effects 0.000 claims description 6
- 230000001464 adherent effect Effects 0.000 claims description 5
- 125000000217 alkyl group Chemical group 0.000 claims description 5
- 239000003139 biocide Substances 0.000 claims description 5
- 239000002178 crystalline material Substances 0.000 claims description 5
- 238000007710 freezing Methods 0.000 claims description 5
- 239000003381 stabilizer Substances 0.000 claims description 5
- 239000003963 antioxidant agent Substances 0.000 claims description 4
- 238000001816 cooling Methods 0.000 claims description 4
- 238000001938 differential scanning calorimetry curve Methods 0.000 claims description 4
- 239000004491 dispersible concentrate Substances 0.000 claims description 4
- 239000004495 emulsifiable concentrate Substances 0.000 claims description 4
- 239000003995 emulsifying agent Substances 0.000 claims description 4
- 125000000524 functional group Chemical group 0.000 claims description 4
- 239000004533 oil dispersion Substances 0.000 claims description 4
- 238000000634 powder X-ray diffraction Methods 0.000 claims description 4
- 239000003755 preservative agent Substances 0.000 claims description 4
- 239000004094 surface-active agent Substances 0.000 claims description 4
- 239000004548 suspo-emulsion Substances 0.000 claims description 4
- 239000002562 thickening agent Substances 0.000 claims description 4
- 239000004562 water dispersible granule Substances 0.000 claims description 4
- 239000000080 wetting agent Substances 0.000 claims description 4
- 239000000969 carrier Substances 0.000 claims description 3
- 230000005855 radiation Effects 0.000 claims description 3
- 239000004606 Fillers/Extenders Substances 0.000 claims description 2
- 239000000839 emulsion Substances 0.000 claims description 2
- 230000001376 precipitating effect Effects 0.000 claims description 2
- 239000000725 suspension Substances 0.000 claims description 2
- 241000196324 Embryophyta Species 0.000 description 33
- 230000000855 fungicidal effect Effects 0.000 description 13
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 150000001875 compounds Chemical class 0.000 description 11
- 238000009472 formulation Methods 0.000 description 11
- 239000000417 fungicide Substances 0.000 description 9
- 239000000047 product Substances 0.000 description 9
- 239000000463 material Substances 0.000 description 8
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 7
- 238000002425 crystallisation Methods 0.000 description 7
- 230000008025 crystallization Effects 0.000 description 7
- 239000000126 substance Substances 0.000 description 7
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 6
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 6
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 6
- 125000004432 carbon atom Chemical group C* 0.000 description 6
- 241000221785 Erysiphales Species 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 235000014113 dietary fatty acids Nutrition 0.000 description 5
- 239000000194 fatty acid Substances 0.000 description 5
- 229930195729 fatty acid Natural products 0.000 description 5
- 150000004665 fatty acids Chemical class 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- PSZYNBSKGUBXEH-UHFFFAOYSA-N naphthalene-1-sulfonic acid Chemical class C1=CC=C2C(S(=O)(=O)O)=CC=CC2=C1 PSZYNBSKGUBXEH-UHFFFAOYSA-N 0.000 description 5
- 150000003839 salts Chemical class 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- ZMYFCFLJBGAQRS-IRXDYDNUSA-N (2R,3S)-epoxiconazole Chemical compound C1=CC(F)=CC=C1[C@@]1(CN2N=CN=C2)[C@H](C=2C(=CC=CC=2)Cl)O1 ZMYFCFLJBGAQRS-IRXDYDNUSA-N 0.000 description 4
- 239000005767 Epoxiconazole Substances 0.000 description 4
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 description 4
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 4
- 230000009471 action Effects 0.000 description 4
- 239000003905 agrochemical Substances 0.000 description 4
- 244000038559 crop plants Species 0.000 description 4
- 239000003085 diluting agent Substances 0.000 description 4
- 239000002002 slurry Substances 0.000 description 4
- 235000013311 vegetables Nutrition 0.000 description 4
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- XTHFKEDIFFGKHM-UHFFFAOYSA-N Dimethoxyethane Chemical compound COCCOC XTHFKEDIFFGKHM-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- WSFSSNUMVMOOMR-UHFFFAOYSA-N Formaldehyde Chemical compound O=C WSFSSNUMVMOOMR-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 150000004996 alkyl benzenes Chemical class 0.000 description 3
- 125000000129 anionic group Chemical group 0.000 description 3
- 150000008366 benzophenones Chemical class 0.000 description 3
- 230000001276 controlling effect Effects 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229910052500 inorganic mineral Inorganic materials 0.000 description 3
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 3
- 235000010755 mineral Nutrition 0.000 description 3
- 239000011707 mineral Substances 0.000 description 3
- 239000002245 particle Substances 0.000 description 3
- 229920000570 polyether Polymers 0.000 description 3
- 230000009467 reduction Effects 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- FAPWRFPIFSIZLT-UHFFFAOYSA-M sodium chloride Inorganic materials [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 3
- 238000001228 spectrum Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- RYAUSSKQMZRMAI-ALOPSCKCSA-N (2S,6R)-4-[3-(4-tert-butylphenyl)-2-methylpropyl]-2,6-dimethylmorpholine Chemical compound C=1C=C(C(C)(C)C)C=CC=1CC(C)CN1C[C@H](C)O[C@H](C)C1 RYAUSSKQMZRMAI-ALOPSCKCSA-N 0.000 description 2
- DURPTKYDGMDSBL-UHFFFAOYSA-N 1-butoxybutane Chemical compound CCCCOCCCC DURPTKYDGMDSBL-UHFFFAOYSA-N 0.000 description 2
- SZNYYWIUQFZLLT-UHFFFAOYSA-N 2-methyl-1-(2-methylpropoxy)propane Chemical compound CC(C)COCC(C)C SZNYYWIUQFZLLT-UHFFFAOYSA-N 0.000 description 2
- KCIZTNZGSBSSRM-UHFFFAOYSA-N 3,4,5-Trimethoxytoluene Chemical compound COC1=CC(C)=CC(OC)=C1OC KCIZTNZGSBSSRM-UHFFFAOYSA-N 0.000 description 2
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- 241000219198 Brassica Species 0.000 description 2
- 235000011331 Brassica Nutrition 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- ZAFNJMIOTHYJRJ-UHFFFAOYSA-N Diisopropyl ether Chemical compound CC(C)OC(C)C ZAFNJMIOTHYJRJ-UHFFFAOYSA-N 0.000 description 2
- LCGLNKUTAGEVQW-UHFFFAOYSA-N Dimethyl ether Chemical compound COC LCGLNKUTAGEVQW-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-UHFFFAOYSA-N Dimethylsulphoxide Chemical compound CS(C)=O IAZDPXIOMUYVGZ-UHFFFAOYSA-N 0.000 description 2
- 241000510928 Erysiphe necator Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N Ethylbenzene Chemical compound CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 2
- 239000005778 Fenpropimorph Substances 0.000 description 2
- 235000008694 Humulus lupulus Nutrition 0.000 description 2
- 238000004566 IR spectroscopy Methods 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- 235000007688 Lycopersicon esculentum Nutrition 0.000 description 2
- 229910019142 PO4 Inorganic materials 0.000 description 2
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 2
- WCUXLLCKKVVCTQ-UHFFFAOYSA-M Potassium chloride Chemical compound [Cl-].[K+] WCUXLLCKKVVCTQ-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 241000208292 Solanaceae Species 0.000 description 2
- 240000003768 Solanum lycopersicum Species 0.000 description 2
- 244000061456 Solanum tuberosum Species 0.000 description 2
- 235000002595 Solanum tuberosum Nutrition 0.000 description 2
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 2
- 229930006000 Sucrose Natural products 0.000 description 2
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 2
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 2
- 241000219094 Vitaceae Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- RDOXTESZEPMUJZ-UHFFFAOYSA-N anisole Chemical compound COC1=CC=CC=C1 RDOXTESZEPMUJZ-UHFFFAOYSA-N 0.000 description 2
- 239000012965 benzophenone Substances 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 229920002678 cellulose Polymers 0.000 description 2
- 235000010980 cellulose Nutrition 0.000 description 2
- 229920001577 copolymer Polymers 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- JHIVVAPYMSGYDF-UHFFFAOYSA-N cyclohexanone Chemical compound O=C1CCCCC1 JHIVVAPYMSGYDF-UHFFFAOYSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 239000008367 deionised water Substances 0.000 description 2
- 229910021641 deionized water Inorganic materials 0.000 description 2
- SWXVUIWOUIDPGS-UHFFFAOYSA-N diacetone alcohol Chemical compound CC(=O)CC(C)(C)O SWXVUIWOUIDPGS-UHFFFAOYSA-N 0.000 description 2
- USIUVYZYUHIAEV-UHFFFAOYSA-N diphenyl ether Chemical compound C=1C=CC=CC=1OC1=CC=CC=C1 USIUVYZYUHIAEV-UHFFFAOYSA-N 0.000 description 2
- 235000013399 edible fruits Nutrition 0.000 description 2
- 150000002148 esters Chemical class 0.000 description 2
- 235000019253 formic acid Nutrition 0.000 description 2
- 235000021021 grapes Nutrition 0.000 description 2
- CATSNJVOTSVZJV-UHFFFAOYSA-N heptan-2-one Chemical compound CCCCCC(C)=O CATSNJVOTSVZJV-UHFFFAOYSA-N 0.000 description 2
- AOGQPLXWSUTHQB-UHFFFAOYSA-N hexyl acetate Chemical compound CCCCCCOC(C)=O AOGQPLXWSUTHQB-UHFFFAOYSA-N 0.000 description 2
- 239000012456 homogeneous solution Substances 0.000 description 2
- HJOVHMDZYOCNQW-UHFFFAOYSA-N isophorone Chemical compound CC1=CC(=O)CC(C)(C)C1 HJOVHMDZYOCNQW-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- YLYBTZIQSIBWLI-UHFFFAOYSA-N octyl acetate Chemical compound CCCCCCCCOC(C)=O YLYBTZIQSIBWLI-UHFFFAOYSA-N 0.000 description 2
- 239000012071 phase Substances 0.000 description 2
- 150000002989 phenols Chemical class 0.000 description 2
- 235000021317 phosphate Nutrition 0.000 description 2
- 229920001451 polypropylene glycol Polymers 0.000 description 2
- 229920001296 polysiloxane Polymers 0.000 description 2
- 235000012015 potatoes Nutrition 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- 235000015424 sodium Nutrition 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L sodium carbonate Substances [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 241000894007 species Species 0.000 description 2
- 239000007858 starting material Substances 0.000 description 2
- 239000005720 sucrose Substances 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- CSUUDNFYSFENAE-UHFFFAOYSA-N (2-methoxyphenyl)-phenylmethanone Chemical class COC1=CC=CC=C1C(=O)C1=CC=CC=C1 CSUUDNFYSFENAE-UHFFFAOYSA-N 0.000 description 1
- QNBTYORWCCMPQP-JXAWBTAJSA-N (Z)-dimethomorph Chemical compound C1=C(OC)C(OC)=CC=C1C(\C=1C=CC(Cl)=CC=1)=C/C(=O)N1CCOCC1 QNBTYORWCCMPQP-JXAWBTAJSA-N 0.000 description 1
- JLHMJWHSBYZWJJ-UHFFFAOYSA-N 1,2-thiazole 1-oxide Chemical class O=S1C=CC=N1 JLHMJWHSBYZWJJ-UHFFFAOYSA-N 0.000 description 1
- PXMNMQRDXWABCY-UHFFFAOYSA-N 1-(4-chlorophenyl)-4,4-dimethyl-3-(1H-1,2,4-triazol-1-ylmethyl)pentan-3-ol Chemical compound C1=NC=NN1CC(O)(C(C)(C)C)CCC1=CC=C(Cl)C=C1 PXMNMQRDXWABCY-UHFFFAOYSA-N 0.000 description 1
- LQDARGUHUSPFNL-UHFFFAOYSA-N 1-[2-(2,4-dichlorophenyl)-3-(1,1,2,2-tetrafluoroethoxy)propyl]1,2,4-triazole Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(COC(F)(F)C(F)F)CN1C=NC=N1 LQDARGUHUSPFNL-UHFFFAOYSA-N 0.000 description 1
- NVJUHMXYKCUMQA-UHFFFAOYSA-N 1-ethoxypropane Chemical compound CCCOCC NVJUHMXYKCUMQA-UHFFFAOYSA-N 0.000 description 1
- OVSKIKFHRZPJSS-UHFFFAOYSA-N 2,4-D Chemical compound OC(=O)COC1=CC=C(Cl)C=C1Cl OVSKIKFHRZPJSS-UHFFFAOYSA-N 0.000 description 1
- STMIIPIFODONDC-UHFFFAOYSA-N 2-(2,4-dichlorophenyl)-1-(1H-1,2,4-triazol-1-yl)hexan-2-ol Chemical compound C=1C=C(Cl)C=C(Cl)C=1C(O)(CCCC)CN1C=NC=N1 STMIIPIFODONDC-UHFFFAOYSA-N 0.000 description 1
- DNBMPXLFKQCOBV-UHFFFAOYSA-N 2-(2-ethoxyethoxy)ethyl n-(1h-benzimidazol-2-yl)carbamate Chemical compound C1=CC=C2NC(NC(=O)OCCOCCOCC)=NC2=C1 DNBMPXLFKQCOBV-UHFFFAOYSA-N 0.000 description 1
- HZJKXKUJVSEEFU-UHFFFAOYSA-N 2-(4-chlorophenyl)-2-(1H-1,2,4-triazol-1-ylmethyl)hexanenitrile Chemical compound C=1C=C(Cl)C=CC=1C(CCCC)(C#N)CN1C=NC=N1 HZJKXKUJVSEEFU-UHFFFAOYSA-N 0.000 description 1
- UFNOUKDBUJZYDE-UHFFFAOYSA-N 2-(4-chlorophenyl)-3-cyclopropyl-1-(1H-1,2,4-triazol-1-yl)butan-2-ol Chemical compound C1=NC=NN1CC(O)(C=1C=CC(Cl)=CC=1)C(C)C1CC1 UFNOUKDBUJZYDE-UHFFFAOYSA-N 0.000 description 1
- MNHVNIJQQRJYDH-UHFFFAOYSA-N 2-[2-(1-chlorocyclopropyl)-3-(2-chlorophenyl)-2-hydroxypropyl]-1,2-dihydro-1,2,4-triazole-3-thione Chemical compound N1=CNC(=S)N1CC(C1(Cl)CC1)(O)CC1=CC=CC=C1Cl MNHVNIJQQRJYDH-UHFFFAOYSA-N 0.000 description 1
- OWDLFBLNMPCXSD-UHFFFAOYSA-N 2-chloro-N-(2,6-dimethylphenyl)-N-(2-oxotetrahydrofuran-3-yl)acetamide Chemical compound CC1=CC=CC(C)=C1N(C(=O)CCl)C1C(=O)OCC1 OWDLFBLNMPCXSD-UHFFFAOYSA-N 0.000 description 1
- PZXLGCIJEFUSLH-UHFFFAOYSA-N 3-bromo-6-methoxy-2-methylbenzoic acid Chemical compound COC1=CC=C(Br)C(C)=C1C(O)=O PZXLGCIJEFUSLH-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- RQDJADAKIFFEKQ-UHFFFAOYSA-N 4-(4-chlorophenyl)-2-phenyl-2-(1,2,4-triazol-1-ylmethyl)butanenitrile Chemical compound C1=CC(Cl)=CC=C1CCC(C=1C=CC=CC=1)(C#N)CN1N=CN=C1 RQDJADAKIFFEKQ-UHFFFAOYSA-N 0.000 description 1
- 102000007469 Actins Human genes 0.000 description 1
- 108010085238 Actins Proteins 0.000 description 1
- GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
- 244000144730 Amygdalus persica Species 0.000 description 1
- 235000017060 Arachis glabrata Nutrition 0.000 description 1
- 244000105624 Arachis hypogaea Species 0.000 description 1
- 235000010777 Arachis hypogaea Nutrition 0.000 description 1
- 235000018262 Arachis monticola Nutrition 0.000 description 1
- 235000007319 Avena orientalis Nutrition 0.000 description 1
- 244000075850 Avena orientalis Species 0.000 description 1
- 235000000832 Ayote Nutrition 0.000 description 1
- 239000005730 Azoxystrobin Substances 0.000 description 1
- 239000005734 Benalaxyl Substances 0.000 description 1
- ZNSMNVMLTJELDZ-UHFFFAOYSA-N Bis(2-chloroethyl)ether Chemical compound ClCCOCCCl ZNSMNVMLTJELDZ-UHFFFAOYSA-N 0.000 description 1
- LSNNMFCWUKXFEE-UHFFFAOYSA-M Bisulfite Chemical compound OS([O-])=O LSNNMFCWUKXFEE-UHFFFAOYSA-M 0.000 description 1
- 239000005740 Boscalid Substances 0.000 description 1
- 240000002791 Brassica napus Species 0.000 description 1
- 235000004977 Brassica sinapistrum Nutrition 0.000 description 1
- 239000005741 Bromuconazole Substances 0.000 description 1
- 239000004322 Butylated hydroxytoluene Substances 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- 0 C*COC1=*c(cc2)c1c(C)c2Br Chemical compound C*COC1=*c(cc2)c1c(C)c2Br 0.000 description 1
- 229910021532 Calcite Inorganic materials 0.000 description 1
- TWFZGCMQGLPBSX-UHFFFAOYSA-N Carbendazim Natural products C1=CC=C2NC(NC(=O)OC)=NC2=C1 TWFZGCMQGLPBSX-UHFFFAOYSA-N 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 239000005747 Chlorothalonil Substances 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 241000219122 Cucurbita Species 0.000 description 1
- 235000009854 Cucurbita moschata Nutrition 0.000 description 1
- 235000009804 Cucurbita pepo subsp pepo Nutrition 0.000 description 1
- 239000005757 Cyproconazole Substances 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 239000005760 Difenoconazole Substances 0.000 description 1
- AQZGPSLYZOOYQP-UHFFFAOYSA-N Diisoamyl ether Chemical compound CC(C)CCOCCC(C)C AQZGPSLYZOOYQP-UHFFFAOYSA-N 0.000 description 1
- 239000005761 Dimethomorph Substances 0.000 description 1
- 239000005762 Dimoxystrobin Substances 0.000 description 1
- 240000002989 Euphorbia neriifolia Species 0.000 description 1
- 239000005775 Fenbuconazole Substances 0.000 description 1
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 1
- 239000005791 Fuberidazole Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 244000068988 Glycine max Species 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 240000005979 Hordeum vulgare Species 0.000 description 1
- 235000007340 Hordeum vulgare Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
- 240000006240 Linum usitatissimum Species 0.000 description 1
- 235000004431 Linum usitatissimum Nutrition 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930195725 Mannitol Natural products 0.000 description 1
- 239000005807 Metalaxyl Substances 0.000 description 1
- 239000005811 Myclobutanil Substances 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 240000007817 Olea europaea Species 0.000 description 1
- 241000233654 Oomycetes Species 0.000 description 1
- 241000233679 Peronosporaceae Species 0.000 description 1
- 239000005818 Picoxystrobin Substances 0.000 description 1
- 241000951259 Podosphaera xanthii Species 0.000 description 1
- 239000004952 Polyamide Substances 0.000 description 1
- 229920002367 Polyisobutene Polymers 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004793 Polystyrene Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 239000005820 Prochloraz Substances 0.000 description 1
- 239000005822 Propiconazole Substances 0.000 description 1
- GOOHAUXETOMSMM-UHFFFAOYSA-N Propylene oxide Chemical compound CC1CO1 GOOHAUXETOMSMM-UHFFFAOYSA-N 0.000 description 1
- 239000005825 Prothioconazole Substances 0.000 description 1
- 235000006040 Prunus persica var persica Nutrition 0.000 description 1
- 239000005869 Pyraclostrobin Substances 0.000 description 1
- 235000004443 Ricinus communis Nutrition 0.000 description 1
- 235000004789 Rosa xanthina Nutrition 0.000 description 1
- 241000109329 Rosa xanthina Species 0.000 description 1
- 241000209056 Secale Species 0.000 description 1
- 235000007238 Secale cereale Nutrition 0.000 description 1
- 239000004113 Sepiolite Substances 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 244000040738 Sesamum orientale Species 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 101710172711 Structural protein Proteins 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 239000005839 Tebuconazole Substances 0.000 description 1
- 239000005840 Tetraconazole Substances 0.000 description 1
- 239000005842 Thiophanate-methyl Substances 0.000 description 1
- 235000021307 Triticum Nutrition 0.000 description 1
- 244000098338 Triticum aestivum Species 0.000 description 1
- 238000010811 Ultra-Performance Liquid Chromatography-Tandem Mass Spectrometry Methods 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- JIAARYAFYJHUJI-UHFFFAOYSA-L Zinc chloride Inorganic materials [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 1
- 239000001089 [(2R)-oxolan-2-yl]methanol Substances 0.000 description 1
- 230000000895 acaricidal effect Effects 0.000 description 1
- 239000000642 acaricide Substances 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- ZCZSIDMEHXZRLG-UHFFFAOYSA-N acetic acid heptyl ester Natural products CCCCCCCOC(C)=O ZCZSIDMEHXZRLG-UHFFFAOYSA-N 0.000 description 1
- PBCJIPOGFJYBJE-UHFFFAOYSA-N acetonitrile;hydrate Chemical compound O.CC#N PBCJIPOGFJYBJE-UHFFFAOYSA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000013543 active substance Substances 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 150000001340 alkali metals Chemical class 0.000 description 1
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 1
- 150000001342 alkaline earth metals Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229910052782 aluminium Inorganic materials 0.000 description 1
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229960000892 attapulgite Drugs 0.000 description 1
- 239000005667 attractant Substances 0.000 description 1
- WFDXOXNFNRHQEC-GHRIWEEISA-N azoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1OC1=CC(OC=2C(=CC=CC=2)C#N)=NC=N1 WFDXOXNFNRHQEC-GHRIWEEISA-N 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- RIOXQFHNBCKOKP-UHFFFAOYSA-N benomyl Chemical compound C1=CC=C2N(C(=O)NCCCC)C(NC(=O)OC)=NC2=C1 RIOXQFHNBCKOKP-UHFFFAOYSA-N 0.000 description 1
- SRSXLGNVWSONIS-UHFFFAOYSA-N benzenesulfonic acid Chemical class OS(=O)(=O)C1=CC=CC=C1 SRSXLGNVWSONIS-UHFFFAOYSA-N 0.000 description 1
- MITFXPHMIHQXPI-UHFFFAOYSA-N benzoxaprofen Natural products N=1C2=CC(C(C(O)=O)C)=CC=C2OC=1C1=CC=C(Cl)C=C1 MITFXPHMIHQXPI-UHFFFAOYSA-N 0.000 description 1
- WVDDGKGOMKODPV-UHFFFAOYSA-N benzyl alcohol Substances OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 1
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 238000010352 biotechnological method Methods 0.000 description 1
- 229920001400 block copolymer Polymers 0.000 description 1
- WYEMLYFITZORAB-UHFFFAOYSA-N boscalid Chemical compound C1=CC(Cl)=CC=C1C1=CC=CC=C1NC(=O)C1=CC=CN=C1Cl WYEMLYFITZORAB-UHFFFAOYSA-N 0.000 description 1
- 229940118790 boscalid Drugs 0.000 description 1
- 238000009395 breeding Methods 0.000 description 1
- 230000001488 breeding effect Effects 0.000 description 1
- HJJVPARKXDDIQD-UHFFFAOYSA-N bromuconazole Chemical compound ClC1=CC(Cl)=CC=C1C1(CN2N=CN=C2)OCC(Br)C1 HJJVPARKXDDIQD-UHFFFAOYSA-N 0.000 description 1
- 235000010354 butylated hydroxytoluene Nutrition 0.000 description 1
- 229940095259 butylated hydroxytoluene Drugs 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical class [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000292 calcium oxide Substances 0.000 description 1
- ODINCKMPIJJUCX-UHFFFAOYSA-N calcium oxide Inorganic materials [Ca]=O ODINCKMPIJJUCX-UHFFFAOYSA-N 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 235000012241 calcium silicate Nutrition 0.000 description 1
- 239000004202 carbamide Substances 0.000 description 1
- 239000006013 carbendazim Substances 0.000 description 1
- JNPZQRQPIHJYNM-UHFFFAOYSA-N carbendazim Chemical compound C1=C[CH]C2=NC(NC(=O)OC)=NC2=C1 JNPZQRQPIHJYNM-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 230000032823 cell division Effects 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 239000004568 cement Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 235000013339 cereals Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- CRQQGFGUEAVUIL-UHFFFAOYSA-N chlorothalonil Chemical compound ClC1=C(Cl)C(C#N)=C(Cl)C(C#N)=C1Cl CRQQGFGUEAVUIL-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 238000004440 column chromatography Methods 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- 238000005520 cutting process Methods 0.000 description 1
- HPXRVTGHNJAIIH-UHFFFAOYSA-N cyclohexanol Chemical compound OC1CCCCC1 HPXRVTGHNJAIIH-UHFFFAOYSA-N 0.000 description 1
- 229930007927 cymene Natural products 0.000 description 1
- 238000010908 decantation Methods 0.000 description 1
- 238000006731 degradation reaction Methods 0.000 description 1
- 239000002274 desiccant Substances 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 230000018109 developmental process Effects 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 229910003460 diamond Inorganic materials 0.000 description 1
- 239000010432 diamond Substances 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- 150000001993 dienes Chemical class 0.000 description 1
- MTHSVFCYNBDYFN-UHFFFAOYSA-N diethylene glycol Chemical compound OCCOCCO MTHSVFCYNBDYFN-UHFFFAOYSA-N 0.000 description 1
- BQYJATMQXGBDHF-UHFFFAOYSA-N difenoconazole Chemical compound O1C(C)COC1(C=1C(=CC(OC=2C=CC(Cl)=CC=2)=CC=1)Cl)CN1N=CN=C1 BQYJATMQXGBDHF-UHFFFAOYSA-N 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- QKIUAMUSENSFQQ-UHFFFAOYSA-N dimethylazanide Chemical compound C[N-]C QKIUAMUSENSFQQ-UHFFFAOYSA-N 0.000 description 1
- WXUZAHCNPWONDH-DYTRJAOYSA-N dimoxystrobin Chemical compound CNC(=O)C(=N\OC)\C1=CC=CC=C1COC1=CC(C)=CC=C1C WXUZAHCNPWONDH-DYTRJAOYSA-N 0.000 description 1
- FBOUIAKEJMZPQG-BLXFFLACSA-N diniconazole-M Chemical compound C1=NC=NN1/C([C@H](O)C(C)(C)C)=C/C1=CC=C(Cl)C=C1Cl FBOUIAKEJMZPQG-BLXFFLACSA-N 0.000 description 1
- 150000002009 diols Chemical class 0.000 description 1
- 238000007598 dipping method Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 239000010459 dolomite Substances 0.000 description 1
- 229910000514 dolomite Inorganic materials 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 239000003337 fertilizer Substances 0.000 description 1
- 235000004426 flaxseed Nutrition 0.000 description 1
- ZEYJIQLVKGBLEM-UHFFFAOYSA-N fuberidazole Chemical compound C1=COC(C=2N=C3[CH]C=CC=C3N=2)=C1 ZEYJIQLVKGBLEM-UHFFFAOYSA-N 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000010353 genetic engineering Methods 0.000 description 1
- 239000010439 graphite Substances 0.000 description 1
- 229910002804 graphite Inorganic materials 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 239000003673 groundwater Substances 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 239000010440 gypsum Substances 0.000 description 1
- 229910052602 gypsum Inorganic materials 0.000 description 1
- JPXGPRBLTIYFQG-UHFFFAOYSA-N heptan-4-yl acetate Chemical compound CCCC(CCC)OC(C)=O JPXGPRBLTIYFQG-UHFFFAOYSA-N 0.000 description 1
- 239000004009 herbicide Substances 0.000 description 1
- 239000010903 husk Substances 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 1
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 150000002576 ketones Chemical class 0.000 description 1
- 239000008101 lactose Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 235000001055 magnesium Nutrition 0.000 description 1
- 239000000391 magnesium silicate Substances 0.000 description 1
- 235000012243 magnesium silicates Nutrition 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000000594 mannitol Substances 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 239000004579 marble Substances 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- AUHZEENZYGFFBQ-UHFFFAOYSA-N mesitylene Substances CC1=CC(C)=CC(C)=C1 AUHZEENZYGFFBQ-UHFFFAOYSA-N 0.000 description 1
- 125000001827 mesitylenyl group Chemical group [H]C1=C(C(*)=C(C([H])=C1C([H])([H])[H])C([H])([H])[H])C([H])([H])[H] 0.000 description 1
- WSFSSNUMVMOOMR-NJFSPNSNSA-N methanone Chemical compound O=[14CH2] WSFSSNUMVMOOMR-NJFSPNSNSA-N 0.000 description 1
- UZKWTJUDCOPSNM-UHFFFAOYSA-N methoxybenzene Substances CCCCOC=C UZKWTJUDCOPSNM-UHFFFAOYSA-N 0.000 description 1
- GHDIHPNJQVDFBL-UHFFFAOYSA-N methoxycyclohexane Chemical compound COC1CCCCC1 GHDIHPNJQVDFBL-UHFFFAOYSA-N 0.000 description 1
- ZQEIXNIJLIKNTD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(methoxyacetyl)alaninate Chemical compound COCC(=O)N(C(C)C(=O)OC)C1=C(C)C=CC=C1C ZQEIXNIJLIKNTD-UHFFFAOYSA-N 0.000 description 1
- CJPQIRJHIZUAQP-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-(phenylacetyl)alaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)CC1=CC=CC=C1 CJPQIRJHIZUAQP-UHFFFAOYSA-N 0.000 description 1
- CIEXPHRYOLIQQD-UHFFFAOYSA-N methyl N-(2,6-dimethylphenyl)-N-2-furoylalaninate Chemical compound CC=1C=CC=C(C)C=1N(C(C)C(=O)OC)C(=O)C1=CC=CO1 CIEXPHRYOLIQQD-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 235000010981 methylcellulose Nutrition 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 150000005673 monoalkenes Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- 230000000877 morphologic effect Effects 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 239000005645 nematicide Substances 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 238000005580 one pot reaction Methods 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 239000011368 organic material Substances 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- UWVQIROCRJWDKL-UHFFFAOYSA-N oxadixyl Chemical compound CC=1C=CC=C(C)C=1N(C(=O)COC)N1CCOC1=O UWVQIROCRJWDKL-UHFFFAOYSA-N 0.000 description 1
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 1
- HFPZCAJZSCWRBC-UHFFFAOYSA-N p-cymene Chemical compound CC(C)C1=CC=C(C)C=C1 HFPZCAJZSCWRBC-UHFFFAOYSA-N 0.000 description 1
- 238000010422 painting Methods 0.000 description 1
- 229910052625 palygorskite Inorganic materials 0.000 description 1
- 235000020232 peanut Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 230000035515 penetration Effects 0.000 description 1
- 230000002688 persistence Effects 0.000 description 1
- 230000002085 persistent effect Effects 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- DLRJIFUOBPOJNS-UHFFFAOYSA-N phenetole Chemical compound CCOC1=CC=CC=C1 DLRJIFUOBPOJNS-UHFFFAOYSA-N 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 150000003014 phosphoric acid esters Chemical class 0.000 description 1
- IBSNKSODLGJUMQ-SDNWHVSQSA-N picoxystrobin Chemical compound CO\C=C(\C(=O)OC)C1=CC=CC=C1COC1=CC=CC(C(F)(F)F)=N1 IBSNKSODLGJUMQ-SDNWHVSQSA-N 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 229920002401 polyacrylamide Polymers 0.000 description 1
- 229920000058 polyacrylate Polymers 0.000 description 1
- 229920002647 polyamide Polymers 0.000 description 1
- 229920001195 polyisoprene Polymers 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920002223 polystyrene Polymers 0.000 description 1
- 229920002635 polyurethane Polymers 0.000 description 1
- 239000004814 polyurethane Substances 0.000 description 1
- 229920002689 polyvinyl acetate Polymers 0.000 description 1
- 239000011118 polyvinyl acetate Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000019422 polyvinyl alcohol Nutrition 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 235000007686 potassium Nutrition 0.000 description 1
- 239000001103 potassium chloride Substances 0.000 description 1
- 235000011164 potassium chloride Nutrition 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- TVLSRXXIMLFWEO-UHFFFAOYSA-N prochloraz Chemical compound C1=CN=CN1C(=O)N(CCC)CCOC1=C(Cl)C=C(Cl)C=C1Cl TVLSRXXIMLFWEO-UHFFFAOYSA-N 0.000 description 1
- STJLVHWMYQXCPB-UHFFFAOYSA-N propiconazole Chemical compound O1C(CCC)COC1(C=1C(=CC(Cl)=CC=1)Cl)CN1N=CN=C1 STJLVHWMYQXCPB-UHFFFAOYSA-N 0.000 description 1
- RUOJZAUFBMNUDX-UHFFFAOYSA-N propylene carbonate Chemical compound CC1COC(=O)O1 RUOJZAUFBMNUDX-UHFFFAOYSA-N 0.000 description 1
- 239000008262 pumice Substances 0.000 description 1
- 235000015136 pumpkin Nutrition 0.000 description 1
- HZRSNVGNWUDEFX-UHFFFAOYSA-N pyraclostrobin Chemical compound COC(=O)N(OC)C1=CC=CC=C1COC1=NN(C=2C=CC(Cl)=CC=2)C=C1 HZRSNVGNWUDEFX-UHFFFAOYSA-N 0.000 description 1
- 239000010453 quartz Substances 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000010076 replication Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 238000012502 risk assessment Methods 0.000 description 1
- 239000003620 semiochemical Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 229910052624 sepiolite Inorganic materials 0.000 description 1
- 235000019355 sepiolite Nutrition 0.000 description 1
- 150000004760 silicates Chemical class 0.000 description 1
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 235000019832 sodium triphosphate Nutrition 0.000 description 1
- 239000011343 solid material Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 230000028070 sporulation Effects 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 230000000087 stabilizing effect Effects 0.000 description 1
- 239000003206 sterilizing agent Substances 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 125000001273 sulfonato group Chemical group [O-]S(*)(=O)=O 0.000 description 1
- 150000003467 sulfuric acid derivatives Chemical class 0.000 description 1
- 229910021653 sulphate ion Inorganic materials 0.000 description 1
- 239000006228 supernatant Substances 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical class NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- BSYVTEYKTMYBMK-UHFFFAOYSA-N tetrahydrofurfuryl alcohol Chemical compound OCC1CCCO1 BSYVTEYKTMYBMK-UHFFFAOYSA-N 0.000 description 1
- 238000001757 thermogravimetry curve Methods 0.000 description 1
- 239000004308 thiabendazole Substances 0.000 description 1
- 235000010296 thiabendazole Nutrition 0.000 description 1
- WJCNZQLZVWNLKY-UHFFFAOYSA-N thiabendazole Chemical compound S1C=NC(C=2NC3=CC=CC=C3N=2)=C1 WJCNZQLZVWNLKY-UHFFFAOYSA-N 0.000 description 1
- 229960004546 thiabendazole Drugs 0.000 description 1
- QGHREAKMXXNCOA-UHFFFAOYSA-N thiophanate-methyl Chemical compound COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC QGHREAKMXXNCOA-UHFFFAOYSA-N 0.000 description 1
- 239000004408 titanium dioxide Substances 0.000 description 1
- 230000009261 transgenic effect Effects 0.000 description 1
- URAYPUMNDPQOKB-UHFFFAOYSA-N triacetin Chemical compound CC(=O)OCC(OC(C)=O)COC(C)=O URAYPUMNDPQOKB-UHFFFAOYSA-N 0.000 description 1
- 229960002622 triacetin Drugs 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical class [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 238000004704 ultra performance liquid chromatography Methods 0.000 description 1
- 238000003828 vacuum filtration Methods 0.000 description 1
- 230000008016 vaporization Effects 0.000 description 1
- 239000003643 water by type Substances 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 235000016804 zinc Nutrition 0.000 description 1
- 239000011592 zinc chloride Substances 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01P—BIOCIDAL, PEST REPELLANT, PEST ATTRACTANT OR PLANT GROWTH REGULATORY ACTIVITY OF CHEMICAL COMPOUNDS OR PREPARATIONS
- A01P3/00—Fungicides
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
- A01N35/04—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aldehyde or keto groups, or thio analogues thereof, directly attached to an aromatic ring system, e.g. acetophenone; Derivatives thereof, e.g. acetals
Definitions
- the present invention relates to a novel form of (3-bromo-6-methoxy-2-methylphenyl) (2, 3, 4-trimethoxy-6-methylphenyl) methanone (metrafenone) , in particular to a novel crystalline form of metrafenone.
- the present invention further relates to a method for the preparation of the novel form of metrafenone.
- the present invention relates to the use of the novel form of metrafenone in agrochemical preparations and in the control of fungicidal infestations.
- 3-bromo-6-methoxy-2-methylphenyl- (2, 3, 4-trimethoxy-6-methylphenyl) methanone having the common name metrafenone, belongs to the chemical class of benzophenones and exhibits a broad spectrum of fungicidal activity.
- Metrafenone has a molecular formula of C 19 H 21 BrO 5 and has the following structure:
- metrafenone is an innovative fungicide and finds particular use in the control of control of oomycetes of powdery mildew produced by Uncinula necator in all commercial varieties of grape vines. Metrafenone is used in the control and prevention of downy mildew and late blight diseases with excellent selectivity and can be applied for the inhibition of all stages of fungal development.
- metrafenone The biochemical mode of action of metrafenone is unknown. However, it has been proposed that the mode of action of metrafenone is through the disruption of actins, which are structural proteins regulating the cell division and function. Based on morphological observations, it appears that metrafenone inhibits the growth of the mycelium on the leaf surface, leaf penetration, and the formation of haustoria and sporulation. The mode of action of metrafenone is discussed by K.S. Opalski, et al., ‘Metrafenone: studies on the mode of action of a novel cereal powdery mildew fungicide’ , Pest Management Science, Volume 62, Issue 5, May 2006, Pages 393 to 401.
- Metrafenone may be used to control and prevent infestations by varieties of powdery mildew (Podosphaera xanthii) or powdery mildew (Erysiphe necator) on a range of crops, including grapes, potatoes, tomatoes and other Solanaceae, cucurbits, leafy and fruiting vegetables, bulb vegetables, brassicas, hops and ornamentals.
- EP 0897904 is concerned with certain benzophenone compounds and discloses compounds having the general formula (I) below.
- the compounds of general formula (I) include metrafenone.
- EP 0897904 discloses a process for producing the benzophenones of general formula (I) , including 2-methoxybenzophenones derivatives. Metrafenone is included in the derivatives that may be formed by the process disclosed in EP 0897904.
- the commercially available metrafenone is usually manufactured by the process described in EP 0897904 and is present in an amorphous form having a melting point in the range of from 89 to 91°C.
- references herein to a ‘residue’ are references to traces of a chemical compound that remain in or on the soil after a particular time. Excess fungicides or harmful derivatives thereof remaining in the soil may be a threat to the environment. This is particularly the case for fungicidal compounds having a long half-life. In particular, fungicide residues can lower the microbiological and biochemical activity of the soil and lead to yield declines. Fungicide residues may also contaminate the groundwater. In light of this, it is important to manage fungicide residues properly, in order to maintain the optimal function of soil ecosystems and to preserve our environment.
- metrafenone when employed to control fungal infestations, for example as summarized above, results in a residue in soil after application in the field.
- Metrafenone in this commercially available form has a significant half-life in soil after application of greater than 120 days.
- the persistance of metrafenone in soil is discussed in ‘Conclusion regarding the peer review of the pesticide risk assessment of the active substance metrafenone finalised: 13 January 2006’ , EFSA Scientific Report (2006) 58, pages 1 to 72. It is indicated that metrafenone is highly persistent in soil under aerobic conditions (DT 50 lab 20°C of 182 to 365 days) .
- crystalline modification I A novel crystalline form of metrafenone has now been found, herein referred to as “crystalline modification I” . Most advantageously, it has been found that the amount of metrafenone residue present in the soil after application of metrafenone in this new crystalline modification I is significantly reduced.
- crystalline modification has the same meaning with the term “crystalline form” .
- a further problem existing in the art is the increasing resistance of fungal species to fungicides. It is has further been found that the resistance of fungal species to metrafenone in this new crystalline modification I is significantly reduced.
- the invention provides a crystalline modification I of (3-bromo-6-methoxy-2-methylphenyl) (2, 3, 4-trimethoxy-6-methylphenyl) methanone (metrafenone) exhibiting at least 3, more preferably 4, 5, 6, 7, 8, 9, 10, 11 or more, of the following reflexes, in any combination, as 2 ⁇ ⁇ 0.2 degrees in an X-ray powder diffractogram (X-RPD) recorded using Cu-K ⁇ radiation at 25°C:
- X-RPD X-ray powder diffractogram
- the crystalline modification I of metrafenone according to the first aspect of the invention exhibits at least 3, more preferably 4, 5, 6, 7, 8, 9, 10, 11 or more, still more preferably all, of the reflexes, in any combination from the following:
- the crystalline modification I of metrafenone according to the first aspect of the invention exhibits the following reflexes:
- the crystalline modification I of metrafenone according to the first aspect of the invention exhibits the following reflexes:
- the crystalline modification I of metrafenone according to the first aspect of the invention exhibits the following reflexes:
- the crystalline modification I of metrafenone according to the first aspect of the invention exhibits the following reflexes:
- the crystalline modification I of metrafenone according to the first aspect of the invention exhibits an X-ray powder diffraction pattern substantially as shown in Figure 1.
- the present invention provides a crystalline modification I of (3-bromo-6-methoxy-2-methylphenyl) (2, 3, 4-trimethoxy-6-methylphenyl) methanone (metrafenone) exhibiting an infrared (IR) spectrum with characteristic functional group vibration peaks at wavenumbers (cm -1 , ⁇ 0.2%) of one or more, more preferably 2, 3, 4, 5, 6, 7 or more, still more preferably all, of 3386, 3259, 3133, 1660, 1635, 1574, 1527, 1503, 1461, 1436, 1383, 1343, 1300, 1265, 1202, 1077, 1061, 1041, 1028, 928, 762, 639 and 562 cm -1 .
- IR infrared
- the crystalline modification I of metrafenone according to the second aspect of the invention exhibits an IR spectrum substantially as shown in Figure 2.
- the crystalline modification I of metrafenone of the second aspect of the present invention further comprises the features hereinbefore described as characterizing the crystalline form of metrafenone of the first aspect of the present invention.
- the present invention provides a crystalline modification I of metrafenone exhibiting a differential scanning calorimetry (DSC) profile having an endothermic melting peak with onset at 97.7°C and peak maximum at 99.5°C, further optionally with a melting enthalpy of 68.38 J/g.
- DSC differential scanning calorimetry
- the crystalline modification according to the third aspect of the present invention exhibits a DSC thermogram substantially as shown in Figure 3.
- the crystalline form of metrafenone of the third aspect of the present invention further comprises the features hereinbefore described as characterizing the crystalline form of metrafenone of one or both of the first and second aspects of the present invention.
- the present invention provides a method for preparing the crystalline modification I of metrafenone, the method comprising the steps of:
- the metrafenone starting material used in step i) of the method may be any suitable metrafenone material.
- the metrafenone employed in step i) of the method is a crystalline modification of metrafenone other than the crystalline modification I of metrafenone, for example the known crystalline form of metrafenone, such as commercially available metrafenone.
- Methods for preparing a suitable metrafenone starting material are known in the art. Commercial metrafenone is manufactured and available on a commercial scale. A particularly suitable method for preparing metrafenone for use in step i) of the aforementioned method is described in EP 0897904.
- step i) of the method metrafenone is dissolved in a solvent system.
- the solvent system may comprise a single solvent or a mixture of two or more solvents. Any suitable solvent that yields the crystalline modification I of metrafenone upon crystallization from the solution may be employed in the solvent system.
- the solvent system comprises one or more solvents selected from ethers, aromatic hydrocarbons, and a mixture thereof.
- the solvent system comprises an ether having the general formula R–O–R 1 , wherein R and R 1 independently represent an alkyl group, preferably a lower alkyl group having from 1 to 8 carbon atoms, more preferably from 1 to 6 carbon atoms, still more preferably from 1 to 4 carbon atoms.
- R and R 1 independently represent an alkyl group, preferably a lower alkyl group having from 1 to 8 carbon atoms, more preferably from 1 to 6 carbon atoms, still more preferably from 1 to 4 carbon atoms.
- the alkyl groups may be straight chain or branched chain.
- the ether in the solvent system is a glycol ether.
- Preferred ethers for use in the solvent system include, for example, methyl t-butyl ether, ethyl propyl ether, n-butyl ether, anisole, phenetole, cyclohexyl methyl ether, dimethyl ether, diethyl ether, dimethyl glycol, diphenyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, methyl tert-butyl ether, and dichlorodiethyl ether.
- ethers are polyethers, including polyethers of ethylene oxide and/or propylene oxide.
- Preferred aromatic hydrocarbon solvents include benzene and alkyl-substituted benzene, preferably C 1 to C 4 alkyl-substituted benzene derivatives, provided that in the case of C 1 alkyl substituents, two or more alkyl substituents are present, more preferably C 1 to C 3 alkyl-substituted benzene derivatives, such as ethyl benzene, xylene, mesitylene and cymene.
- Petroleum fractions within a boiling range of from 70°C to 190°C and ligroin are also suitable as solvents.
- the solvent system comprises one or more solvents selected from the group consisting of aromatic hydrocarbons, ethers and mixtures thereof.
- Particularly preferred solvents are xylene, methyl t-butyl ether and mixtures thereof.
- the crystalline modification I of metrafenone is prepared by dissolving metrafenone in a solvent system to form a metrafenone solution.
- the dissolution of metrafenone may be performed at ambient temperature.
- the solvent system may be heated, preferably to a temperature at or below the reflux temperature of the solvent system.
- the solution of metrafenone is prepared at the reflux temperature of the solvent system.
- concentration of the metrafenone solution depends on such factors as the solubility of metrafenone in the solvent system employed.
- the metrafenone solution prepared in step i) of the method is then used to produce the crystalline modification I of metrafenone. This is achieved by crystallization. Any suitable technique or combination of techniques may be employed to crystallize the crystalline modification I of metrafenone from solution in the solvent system.
- the solution may be cooled, for example to room temperature or to a temperature of from about 0°C to about 20°C to crystallize the desired crystalline form from the solvent.
- the crystalline modification I of metrafenone may be crystallized out of solution by concentrating the solution by removing the solvent system.
- the solvent system may be removed by techniques known in the art, for example by evaporation with or without applying a vacuum, optionally with cooling to below the reflux temperature of the solvent system.
- Production of the crystalline modification I of metrafenone from the solution may also be effected or aided by adding seed crystals to the solution, preferably seed crystals of metrafenone, more preferably seed crystals of the desired crystalline form, that is the crystalline modification I of metrafenone.
- seed crystals acts to promote or accelerate the crystallization.
- the amount of seed crystals added to the metrafenone solution may be any suitable amount required to promote or accelerate crystallization and is typically in the range of 0.001% to 10% by weight based on the weight of metrafenone used to prepare the solution, preferably from 0.001% to 2.5% by weight, more preferably from 0.005 to 0.5% by weight based on the weight of metrafenone used for the preparation of the solution in step (i) .
- the seed crystals, if employed, are added to the concentrated solution at the temperature below the boiling point of the solvent system.
- Crystallization of the crystalline modification I of metrafenone from the solution formed in step i) may be carried out batchwise, semi-continuously or continuously.
- the precipitated crystalline modification I of metrafenone obtained from step ii) of the method may be isolated and revered by solid component separation techniques known in the art, such as filtration, centrifugation and/or decantation.
- the isolated solid is preferably washed with a solvent one or more times.
- the solvent employed in the washing stage consists of or at least comprises one or more components of the solvent system employed for preparation of the metrafenone solution in step i) of the method, as described above.
- the washing step is preferably carried out using the solvent at a temperature from 0°C to room temperature, depending on the solubility of the crystalline metrafenone in the solvent system being employed, in order to minimize or avoid the loss of crystalline material.
- the crystalline modification I of metrafenone is dissolved and recrystallized.
- the washings and/or the solvent system used for crystallization in any of the method steps may be concentrated to obtain solid metrafenone, which may then be recycled for use in step i) of the method.
- the present invention provides a crystalline modification I of metrafenone obtainable by the method hereinbefore described.
- the crystalline metrafenone material has a content of the crystalline modification I of metrafenone of at least 97.5% by weight.
- the present invention provides a fungicidal composition
- a fungicidal composition comprising the crystalline modification I of metrafenone as hereinbefore described and at least one auxiliary.
- the composition may comprise the crystalline modification I of metrafenone in any suitable amount to provide the desired fungicidal effects.
- the amount of the crystalline modification I of metrafenone in the composition is less than 75% by weight of the composition, more preferably less than 50% by weight of the composition, still more preferably less than 40% by weight of the composition, more preferably still in many embodiments less than 25% by weight of the composition.
- the amount of the crystalline modification I of metrafenone in the composition is greater than 0.1% by weight of the composition, more preferably greater than 1% by weight of the composition, still more preferably greater than 5% by weight of the composition, more preferably still in many embodiments greater than 10% by weight of the composition, for example greater than 25% by weight.
- the crystalline modification I of metrafenone is present in the composition in an amount of about 50% by weight.
- metrafenone as a fungicide is well known in the art and metrafenone is used on a commercial scale.
- the crystalline modification I of metrafenone is active in preventing, treating and controlling fungal infestations in plants and plant parts. Techniques of formulating and applying metrafenone are known in the art.
- the crystalline modification I of metrafenone can be formulated and applied in analogous manners to those known and employed in the art for known forms of metrafenone.
- the crystalline modification I of metrafenone may be formulated into any suitable composition.
- the composition is in the form of a suspension concentrate (SC) , an oil dispersion (OD) , water-soluble granules (SG) , a dispersible concentrate (DC) , an emulsifiable concentrate (EC) , an emulsion seed dressing, a suspension seed dressing, granules (GR) , microgranules (MG) , a suspoemulsion (SE) or water-dispersible granules (WG) .
- SC suspension concentrate
- OD oil dispersion
- SG water-soluble granules
- DC dispersible concentrate
- EC emulsifiable concentrate
- emulsion seed dressing emulsion seed dressing
- GR granules
- MG microgranules
- SE suspoemulsion
- WG water-dispersible granules
- the composition is in the form of a
- Formulations containing the crystalline modification I of metrafenone may be prepared using techniques known in the art, for example, by extending the crystalline modification I of metrafenone with water, solvents and carriers, using, if appropriate, emulsifiers and/or dispersants, and/or other auxiliaries.
- the compositions are prepared by combining the crystalline modification I of metrafenone with one or more agriculturally acceptable auxiliaries.
- auxiliaries employed in the composition and their amounts will depend upon the type of formulation and/or the manner in which the formulation is to be applied by the end user.
- Suitable auxiliaries are customary formulation adjuvants or components, such as dispersants, wetting agents, emulsifiers, extenders, carriers, solvents, surfactants, stabilizers, anti-foam agents, anti-freezing agents, preservatives, antioxidants, colourants, thickeners, biocides, solid adherents and inert fillers.
- Such auxiliaries are known in the art and are commercially available. Their use in the formulation of the compositions of the present invention will be apparent to the person skilled in the art.
- Surfactants can be an emulsifier, dispersant or wetting agent of ionic or nonionic type.
- Examples which may be used include, but are not limited to, salts of polyacrylic acids, salts of lignosulphonic acid, salts of phenylsulphonic or naphthalenesulphonic acids, polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines, substituted phenols, especially alkylphenols, sulphosuccinic ester salts, taurine derivatives, especially alkyltaurates, or phosphoric esters of polyethoxylated phenols or alcohols.
- Liquid diluents include, but are not limited to, water, N, N-dimethylamide, dimethyl sulfoxide, N-alkylpyrrolidone, ethylene glycol, polypropylene glycol, propylene carbonate, dibasic esters, paraffins, alkylbenzenes, alkyl naphthalenes, glycerine, triacetine, oils of olive, castor, linseed, sesame, corn, peanut, cotton-seed, soybean, rape-seed and coconut, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, acetates such as hexyl acetate, heptyl acetate and octyl acetate, and alcohols such methanol, cyclohexanol, decanol, benzyl and tetrahydrofurfuryl alcohol, and mixtures thereof.
- the composition may further comprise one or more polymeric stabilizers.
- Suitable polymeric stabilizers that may be used in the present invention include, but are not limited to, polypropylene, polyisobutylene, polyisoprene, copolymers of monoolefins and diolefins, polyacrylates, polystyrene, polyvinyl acetate, polyurethanes or polyamides. Suitable stabilizers are known in the art and are commercially available.
- the composition may further comprise one or more anti-foam agents.
- Suitable anti-foam agents include those substances which can normally be used for this purpose in agrochemical compositions and will be readily apparent to the person skilled in the art. Suitable anti-foam agents are known in the art and are commercially available. Particularly preferred anti-foam agents are mixtures of polydimethylsiloxanes and perfluroalkylphosphonic acids, such as the silicone anti-foam agents (for example commercially available from GE or Compton) . Other examples of anti-foam agents are fatty acids, tallow, and sodium salts.
- the composition may further comprise one or more preservatives.
- Suitable preservatives include those substances which can normally be used for this purpose in agrochemical compositions of this type and again are well known in the art. Suitable examples that may be mentioned include (commercially available from Bayer AG) and (commercially available from Bayer AG) .
- the composition may further comprise one or more antioxidants.
- Suitable antioxidants are substances which can normally be used for this purpose in agrochemical compositions, as is known in the art. Preference is given, for example, to butylated hydroxytoluene.
- the composition may further comprise one or more solid adherents.
- adherents are known in the art and available commercially.
- Suitable solid adherents include organic adhesives, including tackifiers, such as celluloses of substituted celluloses, natural and synthetic polymers in the form of powders, granules, or lattices, and inorganic adhesives such as gypsum, silica, or cement.
- the composition may further comprise one or more inert fillers.
- inert fillers are known in the art and available commercially. Suitable fillers include, for example, natural ground minerals, such as kaolins, aluminas, talc, chalk, quartz, attapulgite, montmorillonite, and diatomaceous earth, or synthetic ground minerals, such as highly dispersed silicic acid, aluminum oxide, silicates, and calcium phosphates and calcium hydrogen phosphates.
- Suitable inert fillers for granules include, for example, crushed and fractionated natural minerals, such as calcite, marble, pumice, sepiolite, and dolomite, or synthetic granules of inorganic and organic ground materials, as well as granules of organic material, such as sawdust, coconut husks, corn cobs, and tobacco stalks.
- inert fillers also include sodium tripolyphosphate and sucrose.
- Solid diluents can be water-soluble or water-insoluble.
- Water-soluble solid diluents include, but are not limited to, salts such as alkali metal phosphates (for example sodium dihydrogen phosphate) , alkaline earth phosphates, sulfates of sodium, potassium, magnesium and zinc, sodium and potassium chloride, sodium acetate, sodium carbonate and sodium benzoate, and sugars and sugar derivatives such as sorbitol, lactose, sucrose and mannitol.
- Examples of water-insoluble solid diluents include, but are not limited to clays, synthetic and diatomaceous silicas, calcium and magnesium silicates, titanium dioxide, aluminum, calcium and zinc oxide, and mixtures thereof.
- Wetting agents include, but are not limited to, alkyl sulfosuccinates, laureates, alkyl sulfates, phosphate esters, acetylenic diols, ethoxyfluornated alcohols, ethoxylated silicones, alkyl phenol ethyoxylates, benzene sulfonates, alkyl-substituted benzene sulfonates, alkyl a-olefin sulfonates, naphthalene sulfonates, alkyl-substituted naphthalene sulfonates, condensates of naphthalene sulfonates and alkyl-substituted naphthalene sulfonates with formaldehyde, and alcohol ethoxylates, and mixtures thereof. Alkyl naphthalene sulphonates, sodium salts are particularly useful for the composition
- Dispersants for use in the formulations may be a non-ionic dispersing agent or an anionic dispersing agent.
- Suitable non-ionic dispersing agents for use in the stabilizing component of the concentrate of the present invention are known in the art and are commercially available.
- the non-ionic dispersing agent is preferably an ethoxylated non-ionic dispersing agent, in particular polytheyleneoxide-polypropyleneoxide block-copolymers. Such compounds are available commercially, for example available from BASF A. G.
- the non-ionic dispersing agent may be a polyoxyethylene fatty acid or polyoxyethylene alcohol.
- such compounds are known in the art and can be prepared by the alkoxylation of fatty acids, alcohols or alkylphenols having from 9 to 24 carbon atoms, more preferably from 12 to 22 carbon atoms, in particular from 14 to 20 carbon atoms.
- the alkoxylation is preferably carried out using ethylene oxide.
- the aliphatic moieties of the fatty acids and alcohols may be straight chained or branched chain.
- Particularly preferred compounds of this class are alkylethoxylates, alkylarylethoxylates and alkyloxyethoxylates, for example available from Clariant GmbH, and available from Clariant GmbH.
- anionic dispersing agents for use in the formulations are known in the art and are commercially available.
- the anionic dispersing agent is preferably a sulfonate, sulphate or phosphate of ammonia, an alkali metal or alkaline earth metal, in particular an alkylnaphthalene sulfonic acid formaldehyde condensate, tristyrylphenols or distyrylphenols.
- Such compounds are available commercially, for example D425, available from Akzo-Nobel, and available from Rhodia Chemical Company.
- Thickening agents include, but are not limited to, guar gum, pectin, casein, carrageenan, xanthan gum, alginates, methylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, and carboxymethylcellulose, and mixtures thereof.
- Synthetic thickening agents include derivatives of the former categories, and also polyvinyl alcohols, polyacrylamides, polyvinylpyrrolidones, various polyethers, their copolymers, as well as polyacrylic acids and their salts, and mixtures thereof. Alkylpolyvinylpyrrolidones are particularly useful for the composition of the invention.
- Anti-freezing agents are known in the art and are commercially available. Suitable anti-freezing agents include urea, glycerine, liquid polyols, for example ethylene glycol, propylene glycol or glycerol. The amount of anti-freezing agents is generally from about 1% to about 20% by weight, in particular from about 5 to about 10%by weight, based on the total weight of the composition.
- Biocides may also be added to the composition according to the invention. Suitable Biocides include those based on isothiazolones, for example from LONZA Inc. or RS from Thor Chemie or MK from Rohm & Haas. The amount of biocides is typically from 0.01% to 0.04% by weight, based on the total weight of composition.
- formulation components can also be used in the present invention such as dyes, drying agents, and the like. These components and their uses are known to one skilled in the art.
- the present invention further provides a method for preventing, treating and/or controlling fungal infestation of a plant, comprising applying to the plant, plant parts, or the surroundings of the plant, a fungicidally effective amount of crystalline modification I of metrafenone as hereinbefore described, or a composition as hereinbefore described.
- the present invention provides the use of the crystalline modification I of metrafenone as hereinbefore described, or a composition as hereinbefore described, for preventing, treating and/or controlling fungal infestations in plants and/or plant parts.
- the crystalline modification I of metrafenone can be employed with other active compounds, such as insecticides, attractants, sterilizing agents, bactericides, acaricides, nematicides, fungicides, growth-regulating substances, herbicides, safeners, fertilizers and semiochemicals, or with agents for improving plant properties.
- active compounds such as insecticides, attractants, sterilizing agents, bactericides, acaricides, nematicides, fungicides, growth-regulating substances, herbicides, safeners, fertilizers and semiochemicals, or with agents for improving plant properties.
- Such other compounds and agents may be included in the same composition as the crystalline modification I of metrafenone or employed in the form of one or more separate compositions.
- Preferred mixing partners of the crystalline modification I of metrafenone can be epoxiconazole, fenpropimorph, pyraclostrobin, picoxystrobin, prothioconazole, cyproconazole, azoxystrobin, tebuconazole, difenoconazole, boscalid, dimethomorph, chlorothalonil, bromuconazole, diniconazole, epoxiconazole, fenbuconazole, fuquinconazole, fusilazole, hexaconazole, prochloraz, propiconazole, tetraconazole, trifumizol, futriafol, myclobutanil, kresomix-methyl, dimoxystrobin, benomyl, carbendazim, debacarb, fuberidazole, thiabendazole, thiophanate-methyl, benalaxyl, ofurace, metalax
- Particular preferred mixing partners are epoxiconazole and the combination of epoxiconazole and fenpropimorph.
- plants and plant parts may be treated with the crystalline modification I of metrafenone in accordance with the present invention.
- plants are to be understood as meaning all plants and plant populations such as desired and undesired wild plants or crop plants, including naturally occurring crop plants.
- Crop plants may be plants which can be obtained by conventional breeding and optimization methods, by biotechnological and genetic engineering methods, or by combinations of these methods, including the transgenic plants and the plant cultivars which can or cannot be protected by plant breeders' rights.
- Plant parts are to be understood as meaning all parts and organs of plants above and below the ground, such as shoots, leaves, needles, stalks, stems, flowers, fruit bodies, fruits, seeds, roots, tubers and rhizomes.
- Harvested materials, and vegetative and generative propagation materials for example, cuttings, tubers, meristem tissue, rhizomes, offsets, seeds, single and multiple plant cells and any other plant tissues, are also considered as being plant parts.
- references to properties are, unless stated otherwise, to properties measured under ambient conditions, that is at atmospheric pressure and at a temperature of about 20°C.
- the term “about” or “around” when used in connection with a numerical amount or range means somewhat more or somewhat less than the stated numerical amount or range, and for example to a deviation of ⁇ 10% of the stated numerical amount or endpoint of the range.
- “Surrounding” as used herein, refers to the place on which the plants are growing, the place on which the plant propagation materials of the plants are sown or the place on which the plant propagation materials of the plants will be sown.
- Treatment according to the invention of the plants and plant parts with the compositions or formulations of the invention may be carried out directly or by allowing the compositions or formulations to act on their surroundings, habitat or storage space by the customary treatment methods.
- customary treatment methods include dipping, spraying, vaporizing, fogging, broadcasting, painting on in the case of propagation material, and applying one or more coats particularly in the case of seeds.
- Metrafenone which is an active ingredient of the fungicidal composition of the invention, is known to be effective against a range of fungi, such as powdery mildew.
- the benefits of the present invention are seen most when the fungicidal composition is applied to prevent, treat and control fungal infestation in growing crops of useful plants, such as grapes, potatoes, tomatoes, barley, oats, peaches, pumpkins, roses, rye, wheat and other Solanaceae, cucurbits, leafy and fruiting vegetables, bulb vegetables, brassicas, hops and ornamentals.
- useful plants such as grapes, potatoes, tomatoes, barley, oats, peaches, pumpkins, roses, rye, wheat and other Solanaceae, cucurbits, leafy and fruiting vegetables, bulb vegetables, brassicas, hops and ornamentals.
- the crystalline modification I of metrafenone prepared using a solvent system comprising an aromatic hydrocarbon and/or an ether exhibits a significantly reduced half-life, in particular under aerobic conditions normally prevailing in soil in the field, leading to a significant reduction in metrafenone residues remaining in the soil after application.
- the present invention provides the use of a solvent system comprising a solvent selected from aromatic hydrocarbons, ethers and mixtures thereof to produce a crystalline form of metrafenone having a significantly reduced half-life.
- the half-life of metrafenone can be reduced from 120 days to between 7 to 14 days, more preferably from 10 to 11 days.
- the half-life of the metrafenone prepared by crystallization from the aforementioned solvent system may be reduced by 90 to 95%.
- the present invention provides in a still further aspect, the use of a solvent system comprising a solvent selected from aromatic hydrocarbons, ethers and mixtures thereof to produce a crystalline form of metrafenone exhibiting reduced residues in soil.
- Figure 1 is an X-ray powder diffractogram (X-RPD) of a crystalline modification I of metrafenone;
- Figure 2 is an infrared (IR) spectrum of a crystalline modification I of metrafenone
- Figure 3 is a differential scanning calorimetry (DSC) thermogram of a crystalline modification I of metrafenone
- Figure 4 is an X-ray powder diffraction spectrum (X-RPD) of an amorphous metrafenone.
- room temperature is to a temperature in the range of from 20 to 25°C.
- Step size 0.03 degree 2-theta Count time: 1.0 second Maximum peak intensity: 1705 counts per second Scan range: 3-60 degrees 2-theta
- the IR spectrum was measured with the resolution of 4 cm -1 and with the number of scans being 16 for the crystallized samples.
- the crystalline modification I of metrafenone can be identified by its characteristic functional group vibration peaks at wavenumbers (cm -1 , ⁇ 0.2%) of one or more of 3386, 3259, 3133, 1660, 1635, 1574, 1527, 1503, 1461, 1436, 1383, 1343, 1300, 1265, 1202, 1077, 1061, 1041, 1028, 928, 762, 639 and 562 cm -1 as shown in Figure 2.
- Example 1 Preparation of crystalline metrafenone in accordance with the disclosure of EP 0897904 (Example 6C)
- the solid material was collected by vacuum filtration, washed with cold petrol ethers: diisopropylether (1: 1 v/v) and dried, yielding white solid (2.2 g, 54%) , having a melting point 89 to 91°C.
- reaction sequence may be illustrated as follows:
- the X-ray powder diffraction pattern of the resulting metrafenone product has no significant signals, which indicates the metrafenone product prepared in accordance with the disclosure of EP 0897904 is amorphous.
- Example 1 was repeated a few times and the solid metrafenone obtained was combined. 4 g of the metrafenone from Example 1 was placed in a 3-neck round bottom flask along with 25 mL of xylene and the resulting slurry was heated to 65°C to get a homogeneous solution. The insoluble particles, if any, were removed by filtration and the solution was slowly cooled to ambient temperature. Fine crystals were formed during the cooling and the mixture was stirred at ambient temperature for 2 hours.
- the slurry was filtered and washed with 3 mL of cooled xylene.
- the filtered crystals were dried under vacuum at 40°C in order to remove the xylene traces from the crystalline product.
- the crystalline product thus obtained had a purity of 98%and the yield was found to be about 90%.
- the crystals were analyzed by X-RPD, IR spectrometry and DSC and found to be a crystalline modification I of metrafenone having the characteristics shown in Figure 1, Figure 2 and Figure 3 respectively.
- the IR spectrum of the crystalline metrafenone exhibited the functional group characteristic vibration peaks at wavenumbers of one or more of 3386, 3259, 3133, 1660, 1635, 1574, 1527, 1503, 1461, 1436, 1383, 1343, 1300, 1265, 1202, 1077, 1061, 1041, 1028, 928, 762, 639 and 562 cm -1 as shown in Figure 2.
- the DSC thermogram of the crystalline metrafenone exhibited an endothermic melting peak maximum at 99.5°C as shown in Figure 3.
- Example 2 4 g of the metrafenone sample prepared in Example 1 was placed in a 3-neck round bottom flask along with 30 mL of methyl t-butyl ether and the resulting slurry was heated to 40°C to get a homogeneous solution. The insoluble particles, if any, were removed by filtration and the solution was slowly cooled to ambient temperature. Fine crystals were formed during the cooling and the mixture was stirred at ambient temperature for 2 hours.
- the crystalline product thus obtained had a purity of 98% and the yield was found to be about 88%.
- the crystalline modification I of metrafenone was obtained, as determined using X-RPD, IR spectrometry and DSC analysis.
- Samples were prepared by mixing all the components listed in Table 2 uniformly and grinding with a Dyno-Mill (manufactured by Willy A. Bachofen AG) to obtain a suspension concentrate.
- compositions S2 and S3 contain the crystalline modification I of metrafenone and are embodiments of the present invention.
- Composition S1 is a comparative example.
- a 140g soil sample was collected from the field and divided into 14 different pots (6cm diameter plastic pots) .
- the metrafenone product obtained in Examples 1 to 3 and the compositions S1, S2 and S3 prepared in Example 4 were each added to the soil in two pots, to provide two replications, in an amount such that the final concentration of metrafenone in the soil in the pots was 50ppm.
- metrafenone prepared by recrystallization from a solvent system of 15% wt ethyl acetate in heptane was also added to the soil in one pot, to provide a further comparison.
- Untreated soil was used as a control.
- the amount of metrafenone remaining in the soil in each pot was determined at regular intervals after treatment, as follows:
- the supernatant was collected and filtered through a 0.2 m membrane for analysis using chromatography, as follows.
- the retention time of metrafenone in the column is 2.87 minutes.
- the metrafenone product of the prior art exhibited a half-life in the soil of about 120 days.
- the crystalline modification I of metrafenone according to the present invention exhibited a significantly reduced half-life in the soil, in particular between 7 and 14 days, more particularly from 10 to 11 days.
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Plant Pathology (AREA)
- Wood Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Agronomy & Crop Science (AREA)
- General Health & Medical Sciences (AREA)
- Dentistry (AREA)
- Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Chemical & Material Sciences (AREA)
- Pest Control & Pesticides (AREA)
- Mycology (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Abstract
A crystalline modification I of (3-bromo-6-methoxy-2-methylphenyl) (2, 3, 4-trimethoxy-6-methylphenyl) methanone (metrafenone) is provided. A method of preparing the crystalline modification I, a composition comprising the crystalline modification I and its use in controlling fungal infestations are also provided.
Description
CROSS REFERENCE TO RELATED APPLICATIONS
This application claims the priority of GB 2003282.7, filed on October 6, 2020, titled with “A NOVEL FORM OF METRAFENONE, A PROCESS FOR ITS PREPARATION AND USE OF THE SAME” , and the disclosure of which is hereby incorporated by reference.
The present invention relates to a novel form of (3-bromo-6-methoxy-2-methylphenyl) (2, 3, 4-trimethoxy-6-methylphenyl) methanone (metrafenone) , in particular to a novel crystalline form of metrafenone. The present invention further relates to a method for the preparation of the novel form of metrafenone. Still further, the present invention relates to the use of the novel form of metrafenone in agrochemical preparations and in the control of fungicidal infestations.
3-bromo-6-methoxy-2-methylphenyl- (2, 3, 4-trimethoxy-6-methylphenyl) methanone, having the common name metrafenone, belongs to the chemical class of benzophenones and exhibits a broad spectrum of fungicidal activity. Metrafenone has a molecular formula of C
19H
21BrO
5 and has the following structure:
metrafenone is an innovative fungicide and finds particular use in the control of control of oomycetes of powdery mildew produced by Uncinula necator in all commercial varieties of grape vines. Metrafenone is used in the control and prevention of downy mildew and late blight diseases with excellent selectivity and can be applied for the inhibition of all stages of fungal development.
The biochemical mode of action of metrafenone is unknown. However, it has been proposed that the mode of action of metrafenone is through the disruption of actins, which are structural proteins regulating the cell division and function. Based on morphological observations, it appears that metrafenone inhibits the growth of the mycelium on the leaf surface, leaf penetration, and the formation of haustoria and sporulation. The mode of action of metrafenone is discussed by K.S. Opalski, et al., ‘Metrafenone: studies on the mode of action of a novel cereal powdery mildew fungicide’ , Pest Management Science, Volume 62, Issue 5, May 2006, Pages 393 to 401.
Metrafenone may be used to control and prevent infestations by varieties of powdery mildew (Podosphaera xanthii) or powdery mildew (Erysiphe necator) on a range of crops, including grapes, potatoes, tomatoes and other Solanaceae, cucurbits, leafy and fruiting vegetables, bulb vegetables, brassicas, hops and ornamentals.
EP 0897904 is concerned with certain benzophenone compounds and discloses compounds having the general formula (I) below.
The compounds of general formula (I) include metrafenone.
EP 0897904 discloses a process for producing the benzophenones of general formula (I) , including 2-methoxybenzophenones derivatives. Metrafenone is included in the derivatives that may be formed by the process disclosed in EP 0897904.
The commercially available metrafenone is usually manufactured by the process described in EP 0897904 and is present in an amorphous form having a melting point in the range of from 89 to 91℃.
References herein to a ‘residue’ are references to traces of a chemical compound that remain in or on the soil after a particular time. Excess fungicides or harmful derivatives thereof remaining in the soil may be a threat to the environment. This is particularly the case for fungicidal compounds having a long half-life. In particular, fungicide residues can lower the microbiological and biochemical activity of the soil and lead to yield declines. Fungicide residues may also contaminate the groundwater. In light of this, it is important to manage fungicide residues properly, in order to maintain the optimal function of soil ecosystems and to preserve our environment.
It has been found that commercially available metrafenone, when employed to control fungal infestations, for example as summarized above, results in a residue in soil after application in the field. Metrafenone in this commercially available form has a significant half-life in soil after application of greater than 120 days. In particular, the persistance of metrafenone in soil is discussed in ‘Conclusion regarding the peer review of the pesticide risk assessment of the active substance metrafenone finalised: 13 January 2006’ , EFSA Scientific Report (2006) 58, pages 1 to 72. It is indicated that metrafenone is highly persistent in soil under aerobic conditions (DT
50 lab 20℃ of 182 to 365 days) . The results of a further study are reported, in which degradation proceeded at a slower rate with 82% AR remaining as parent after 120 days (extrapolated DT
50 of 693 days) . As a result, metrafenone remains active in the soil for a significant period of time after application to the plants or locus being treated.
There is therefore a need for a way to reduce the length of time metrafenone residues remain active in the soil after application to the plants and their locus.
SUMMARY
A novel crystalline form of metrafenone has now been found, herein referred to as “crystalline modification I” . Most advantageously, it has been found that the amount of metrafenone residue present in the soil after application of metrafenone in this new crystalline modification I is significantly reduced. In the context, the term “crystalline modification” has the same meaning with the term “crystalline form” .
A further problem existing in the art is the increasing resistance of fungal species to fungicides. It is has further been found that the resistance of fungal species to metrafenone in this new crystalline modification I is significantly reduced.
In a first aspect, the invention provides a crystalline modification I of (3-bromo-6-methoxy-2-methylphenyl) (2, 3, 4-trimethoxy-6-methylphenyl) methanone (metrafenone) exhibiting at least 3, more preferably 4, 5, 6, 7, 8, 9, 10, 11 or more, of the following reflexes, in any combination, as 2θ ± 0.2 degrees in an X-ray powder diffractogram (X-RPD) recorded using Cu-Kα radiation at 25℃:
2θ = 8.6 ± 0.2 (1)
2θ = 10.0 ± 0.2 (2)
2θ = 10.6 ± 0.2 (3)
2θ = 11.5 ± 0.2 (4)
2θ = 12.2 ± 0.2 (5)
2θ = 15.6 ± 0.2 (6)
2θ = 17.3 ± 0.2 (7)
2θ = 20.5 ± 0.2 (8)
2θ = 21.7 ± 0.2 (9)
2θ = 22.6 ± 0.2 (10)
2θ = 25.0 ± 0.2 (11)
2θ = 25.6 ± 0.2 (12)
2θ = 25.7 ± 0.2 (13)
2θ = 27.3 ± 0.2 (14)
2θ = 28.4 ± 0.2 (15)
2θ = 28.9 ± 0.2 (16)
2θ = 32.1 ± 0.2 (17) .
In one preferred embodiment, the crystalline modification I of metrafenone according to the first aspect of the invention, exhibits at least 3, more preferably 4, 5, 6, 7, 8, 9, 10, 11 or more, still more preferably all, of the reflexes, in any combination from the following:
2θ = 8.6 ± 0.2 (1)
2θ = 10.0 ± 0.2 (2)
2θ = 10.6 ± 0.2 (3)
2θ = 11.5 ± 0.2 (4)
2θ = 12.2 ± 0.2 (5)
2θ = 15.6 ± 0.2 (6)
2θ = 17.3 ± 0.2 (7)
2θ = 20.5 ± 0.2 (8)
2θ = 21.7 ± 0.2 (9)
2θ = 22.6 ± 0.2 (10)
2θ = 25.0 ± 0.2 (11)
2θ = 27.3 ± 0.2 (14)
2θ = 32.1 ± 0.2 (17) .
In one preferred embodiment, the crystalline modification I of metrafenone according to the first aspect of the invention, exhibits the following reflexes:
2θ = 8.6 ± 0.2 (1)
2θ = 11.5 ± 0.2 (4)
2θ = 25.0 ± 0.2 (11) .
In one preferred embodiment, the crystalline modification I of metrafenone according to the first aspect of the invention, exhibits the following reflexes:
2θ = 8.6 ± 0.2 (1)
2θ = 11.5 ± 0.2 (4)
2θ = 22.6 ± 0.2 (10)
2θ = 25.0 ± 0.2 (11) .
In one preferred embodiment, the crystalline modification I of metrafenone according to the first aspect of the invention, exhibits the following reflexes:
2θ = 8.6 ± 0.2 (1)
2θ = 11.5 ± 0.2 (4)
2θ = 17.3 ± 0.2 (7)
2θ = 20.5 ± 0.2 (8)
2θ = 22.6 ± 0.2 (10)
2θ = 25.0 ± 0.2 (11) .
In one preferred embodiment, the crystalline modification I of metrafenone according to the first aspect of the invention, exhibits the following reflexes:
2θ = 8.6 ± 0.2 (1)
2θ = 10.0 ± 0.2 (2)
2θ = 11.5 ± 0.2 (4)
2θ = 17.3 ± 0.2 (7)
2θ = 20.5 ± 0.2 (8)
2θ = 22.6 ± 0.2 (10)
2θ = 25.0 ± 0.2 (11) .
In one preferred embodiment, the crystalline modification I of metrafenone according to the first aspect of the invention exhibits an X-ray powder diffraction pattern substantially as shown in Figure 1.
In a second aspect, the present invention provides a crystalline modification I of (3-bromo-6-methoxy-2-methylphenyl) (2, 3, 4-trimethoxy-6-methylphenyl) methanone (metrafenone) exhibiting an infrared (IR) spectrum with characteristic functional group vibration peaks at wavenumbers (cm
-1, ± 0.2%) of one or more, more preferably 2, 3, 4, 5, 6, 7 or more, still more preferably all, of 3386, 3259, 3133, 1660, 1635, 1574, 1527, 1503, 1461, 1436, 1383, 1343, 1300, 1265, 1202, 1077, 1061, 1041, 1028, 928, 762, 639 and 562 cm
-1.
In one preferred embodiment, the crystalline modification I of metrafenone according to the second aspect of the invention exhibits an IR spectrum substantially as shown in Figure 2.
In one preferred embodiment, the crystalline modification I of metrafenone of the second aspect of the present invention further comprises the features hereinbefore described as characterizing the crystalline form of metrafenone of the first aspect of the present invention.
In a third aspect, the present invention provides a crystalline modification I of metrafenone exhibiting a differential scanning calorimetry (DSC) profile having an endothermic melting peak with onset at 97.7℃ and peak maximum at 99.5℃, further optionally with a melting enthalpy of 68.38 J/g.
In one preferred embodiment, the crystalline modification according to the third aspect of the present invention exhibits a DSC thermogram substantially as shown in Figure 3.
In one preferred embodiment, the crystalline form of metrafenone of the third aspect of the present invention further comprises the features hereinbefore described as characterizing the crystalline form of metrafenone of one or both of the first and second aspects of the present invention.
It has been found that the crystalline modification I of metrafenone exhibits a significant improvement on residue control in soil, in particular resulting in a significant reduction in the metrafenone residue in the soil after application, which significantly increase the environmental safety.
In a further aspect, the present invention provides a method for preparing the crystalline modification I of metrafenone, the method comprising the steps of:
i) dissolving metrafenone in a solvent system comprising one or more solvents;
ii) precipitating the dissolved metrafenone from solution in the solvent system to yield the crystalline modification I of metrafenone; and
iii) isolating the precipitated crystalline modification I of metrafenone.
The metrafenone starting material used in step i) of the method may be any suitable metrafenone material. In one embodiment, the metrafenone employed in step i) of the method is a crystalline modification of metrafenone other than the crystalline modification I of metrafenone, for example the known crystalline form of metrafenone, such as commercially available metrafenone. Methods for preparing a suitable metrafenone starting material are known in the art. Commercial metrafenone is manufactured and available on a commercial scale. A particularly suitable method for preparing metrafenone for use in step i) of the aforementioned method is described in EP 0897904.
As noted above, in step i) of the method, metrafenone is dissolved in a solvent system. The solvent system may comprise a single solvent or a mixture of two or more solvents. Any suitable solvent that yields the crystalline modification I of metrafenone upon crystallization from the solution may be employed in the solvent system. In one preferred embodiment, the solvent system comprises one or more solvents selected from ethers, aromatic hydrocarbons, and a mixture thereof.
In one embodiment, the solvent system comprises an ether having the general formula R–O–R
1, wherein R and R
1 independently represent an alkyl group, preferably a lower alkyl group having from 1 to 8 carbon atoms, more preferably from 1 to 6 carbon atoms, still more preferably from 1 to 4 carbon atoms. The alkyl groups may be straight chain or branched chain.
In one embodiment, the ether in the solvent system is a glycol ether.
Preferred ethers for use in the solvent system include, for example, methyl t-butyl ether, ethyl propyl ether, n-butyl ether, anisole, phenetole, cyclohexyl methyl ether, dimethyl ether, diethyl ether, dimethyl glycol, diphenyl ether, di-n-butyl ether, diisobutyl ether, diisoamyl ether, ethylene glycol dimethyl ether, methyl tert-butyl ether, and dichlorodiethyl ether.
Another examples of the ether are polyethers, including polyethers of ethylene oxide and/or propylene oxide.
Preferred aromatic hydrocarbon solvents include benzene and alkyl-substituted benzene, preferably C
1 to C
4 alkyl-substituted benzene derivatives, provided that in the case of C
1 alkyl substituents, two or more alkyl substituents are present, more preferably C
1 to C
3 alkyl-substituted benzene derivatives, such as ethyl benzene, xylene, mesitylene and cymene.
Petroleum fractions within a boiling range of from 70℃ to 190℃ and ligroin are also suitable as solvents.
In a preferred embodiment, the solvent system comprises one or more solvents selected from the group consisting of aromatic hydrocarbons, ethers and mixtures thereof. Particularly preferred solvents are xylene, methyl t-butyl ether and mixtures thereof.
In step i) of the method of the present invention, the crystalline modification I of metrafenone is prepared by dissolving metrafenone in a solvent system to form a metrafenone solution. The dissolution of metrafenone may be performed at ambient temperature. Alternatively, the solvent system may be heated, preferably to a temperature at or below the reflux temperature of the solvent system. In one embodiment, the solution of metrafenone is prepared at the reflux temperature of the solvent system. The concentration of the metrafenone solution depends on such factors as the solubility of metrafenone in the solvent system employed.
The metrafenone solution prepared in step i) of the method is then used to produce the crystalline modification I of metrafenone. This is achieved by crystallization. Any suitable technique or combination of techniques may be employed to crystallize the crystalline modification I of metrafenone from solution in the solvent system.
For example, the solution may be cooled, for example to room temperature or to a temperature of from about 0℃ to about 20℃ to crystallize the desired crystalline form from the solvent.
Alternatively, or in addition, the crystalline modification I of metrafenone may be crystallized out of solution by concentrating the solution by removing the solvent system. The solvent system may be removed by techniques known in the art, for example by evaporation with or without applying a vacuum, optionally with cooling to below the reflux temperature of the solvent system.
Production of the crystalline modification I of metrafenone from the solution may also be effected or aided by adding seed crystals to the solution, preferably seed crystals of metrafenone, more preferably seed crystals of the desired crystalline form, that is the crystalline modification I of metrafenone. The addition of seed crystals acts to promote or accelerate the crystallization.
The amount of seed crystals added to the metrafenone solution may be any suitable amount required to promote or accelerate crystallization and is typically in the range of 0.001% to 10% by weight based on the weight of metrafenone used to prepare the solution, preferably from 0.001% to 2.5% by weight, more preferably from 0.005 to 0.5% by weight based on the weight of metrafenone used for the preparation of the solution in step (i) . Preferably, the seed crystals, if employed, are added to the concentrated solution at the temperature below the boiling point of the solvent system.
Crystallization of the crystalline modification I of metrafenone from the solution formed in step i) may be carried out batchwise, semi-continuously or continuously.
The precipitated crystalline modification I of metrafenone obtained from step ii) of the method may be isolated and revered by solid component separation techniques known in the art, such as filtration, centrifugation and/or decantation.
Thereafter, the isolated solid is preferably washed with a solvent one or more times. Preferably, the solvent employed in the washing stage consists of or at least comprises one or more components of the solvent system employed for preparation of the metrafenone solution in step i) of the method, as described above. The washing step is preferably carried out using the solvent at a temperature from 0℃ to room temperature, depending on the solubility of the crystalline metrafenone in the solvent system being employed, in order to minimize or avoid the loss of crystalline material.
In one embodiment of the method of the invention, the crystalline modification I of metrafenone is dissolved and recrystallized. The washings and/or the solvent system used for crystallization in any of the method steps may be concentrated to obtain solid metrafenone, which may then be recycled for use in step i) of the method.
In a further aspect, the present invention provides a crystalline modification I of metrafenone obtainable by the method hereinbefore described.
In the present invention, it is preferred that the crystalline metrafenone material has a content of the crystalline modification I of metrafenone of at least 97.5% by weight.
In a further aspect, the present invention provides a fungicidal composition comprising the crystalline modification I of metrafenone as hereinbefore described and at least one auxiliary.
The composition may comprise the crystalline modification I of metrafenone in any suitable amount to provide the desired fungicidal effects. Preferably, the amount of the crystalline modification I of metrafenone in the composition is less than 75% by weight of the composition, more preferably less than 50% by weight of the composition, still more preferably less than 40% by weight of the composition, more preferably still in many embodiments less than 25% by weight of the composition. Preferably, the amount of the crystalline modification I of metrafenone in the composition is greater than 0.1% by weight of the composition, more preferably greater than 1% by weight of the composition, still more preferably greater than 5% by weight of the composition, more preferably still in many embodiments greater than 10% by weight of the composition, for example greater than 25% by weight. In many embodiments, the crystalline modification I of metrafenone is present in the composition in an amount of about 50% by weight.
The use of metrafenone as a fungicide is well known in the art and metrafenone is used on a commercial scale. The crystalline modification I of metrafenone is active in preventing, treating and controlling fungal infestations in plants and plant parts. Techniques of formulating and applying metrafenone are known in the art. The crystalline modification I of metrafenone can be formulated and applied in analogous manners to those known and employed in the art for known forms of metrafenone.
The crystalline modification I of metrafenone may be formulated into any suitable composition. Such formulations and their preparation are known in the art. Preferably, the composition is in the form of a suspension concentrate (SC) , an oil dispersion (OD) , water-soluble granules (SG) , a dispersible concentrate (DC) , an emulsifiable concentrate (EC) , an emulsion seed dressing, a suspension seed dressing, granules (GR) , microgranules (MG) , a suspoemulsion (SE) or water-dispersible granules (WG) . In one preferred embodiment, the composition is in the form of a suspension concentrate (SC) .
Formulations containing the crystalline modification I of metrafenone may be prepared using techniques known in the art, for example, by extending the crystalline modification I of metrafenone with water, solvents and carriers, using, if appropriate, emulsifiers and/or dispersants, and/or other auxiliaries.
The compositions are prepared by combining the crystalline modification I of metrafenone with one or more agriculturally acceptable auxiliaries. The auxiliaries employed in the composition and their amounts will depend upon the type of formulation and/or the manner in which the formulation is to be applied by the end user. Suitable auxiliaries are customary formulation adjuvants or components, such as dispersants, wetting agents, emulsifiers, extenders, carriers, solvents, surfactants, stabilizers, anti-foam agents, anti-freezing agents, preservatives, antioxidants, colourants, thickeners, biocides, solid adherents and inert fillers. Such auxiliaries are known in the art and are commercially available. Their use in the formulation of the compositions of the present invention will be apparent to the person skilled in the art.
Surfactants can be an emulsifier, dispersant or wetting agent of ionic or nonionic type.
Examples which may be used include, but are not limited to, salts of polyacrylic acids, salts of lignosulphonic acid, salts of phenylsulphonic or naphthalenesulphonic acids, polycondensates of ethylene oxide with fatty alcohols or with fatty acids or with fatty amines, substituted phenols, especially alkylphenols, sulphosuccinic ester salts, taurine derivatives, especially alkyltaurates, or phosphoric esters of polyethoxylated phenols or alcohols.
Liquid diluents include, but are not limited to, water, N, N-dimethylamide, dimethyl sulfoxide, N-alkylpyrrolidone, ethylene glycol, polypropylene glycol, propylene carbonate, dibasic esters, paraffins, alkylbenzenes, alkyl naphthalenes, glycerine, triacetine, oils of olive, castor, linseed, sesame, corn, peanut, cotton-seed, soybean, rape-seed and coconut, ketones such as cyclohexanone, 2-heptanone, isophorone and 4-hydroxy-4-methyl-2-pentanone, acetates such as hexyl acetate, heptyl acetate and octyl acetate, and alcohols such methanol, cyclohexanol, decanol, benzyl and tetrahydrofurfuryl alcohol, and mixtures thereof.
The composition may further comprise one or more polymeric stabilizers. Suitable polymeric stabilizers that may be used in the present invention include, but are not limited to, polypropylene, polyisobutylene, polyisoprene, copolymers of monoolefins and diolefins, polyacrylates, polystyrene, polyvinyl acetate, polyurethanes or polyamides. Suitable stabilizers are known in the art and are commercially available.
The composition may further comprise one or more anti-foam agents. Suitable anti-foam agents include those substances which can normally be used for this purpose in agrochemical compositions and will be readily apparent to the person skilled in the art. Suitable anti-foam agents are known in the art and are commercially available. Particularly preferred anti-foam agents are mixtures of polydimethylsiloxanes and perfluroalkylphosphonic acids, such as the silicone anti-foam agents (for example commercially available from GE or Compton) . Other examples of anti-foam agents are fatty acids, tallow, and sodium salts.
The composition may further comprise one or more preservatives. Suitable preservatives include those substances which can normally be used for this purpose in agrochemical compositions of this type and again are well known in the art. Suitable examples that may be mentioned include
(commercially available from Bayer AG) and
(commercially available from Bayer AG) .
The composition may further comprise one or more antioxidants. Suitable antioxidants are substances which can normally be used for this purpose in agrochemical compositions, as is known in the art. Preference is given, for example, to butylated hydroxytoluene.
The composition may further comprise one or more solid adherents. Such adherents are known in the art and available commercially. Suitable solid adherents include organic adhesives, including tackifiers, such as celluloses of substituted celluloses, natural and synthetic polymers in the form of powders, granules, or lattices, and inorganic adhesives such as gypsum, silica, or cement.
The composition may further comprise one or more inert fillers. Such inert fillers are known in the art and available commercially. Suitable fillers include, for example, natural ground minerals, such as kaolins, aluminas, talc, chalk, quartz, attapulgite, montmorillonite, and diatomaceous earth, or synthetic ground minerals, such as highly dispersed silicic acid, aluminum oxide, silicates, and calcium phosphates and calcium hydrogen phosphates. Suitable inert fillers for granules include, for example, crushed and fractionated natural minerals, such as calcite, marble, pumice, sepiolite, and dolomite, or synthetic granules of inorganic and organic ground materials, as well as granules of organic material, such as sawdust, coconut husks, corn cobs, and tobacco stalks. Examples of inert fillers also include sodium tripolyphosphate and sucrose.
Solid diluents can be water-soluble or water-insoluble. Water-soluble solid diluents include, but are not limited to, salts such as alkali metal phosphates (for example sodium dihydrogen phosphate) , alkaline earth phosphates, sulfates of sodium, potassium, magnesium and zinc, sodium and potassium chloride, sodium acetate, sodium carbonate and sodium benzoate, and sugars and sugar derivatives such as sorbitol, lactose, sucrose and mannitol. Examples of water-insoluble solid diluents include, but are not limited to clays, synthetic and diatomaceous silicas, calcium and magnesium silicates, titanium dioxide, aluminum, calcium and zinc oxide, and mixtures thereof.
Wetting agents include, but are not limited to, alkyl sulfosuccinates, laureates, alkyl sulfates, phosphate esters, acetylenic diols, ethoxyfluornated alcohols, ethoxylated silicones, alkyl phenol ethyoxylates, benzene sulfonates, alkyl-substituted benzene sulfonates, alkyl a-olefin sulfonates, naphthalene sulfonates, alkyl-substituted naphthalene sulfonates, condensates of naphthalene sulfonates and alkyl-substituted naphthalene sulfonates with formaldehyde, and alcohol ethoxylates, and mixtures thereof. Alkyl naphthalene sulphonates, sodium salts are particularly useful for the composition of the invention.
Dispersants for use in the formulations may be a non-ionic dispersing agent or an anionic dispersing agent. Suitable non-ionic dispersing agents for use in the stabilizing component of the concentrate of the present invention are known in the art and are commercially available. The non-ionic dispersing agent is preferably an ethoxylated non-ionic dispersing agent, in particular polytheyleneoxide-polypropyleneoxide block-copolymers. Such compounds are available commercially, for example
available from BASF A. G.
Alternatively, the non-ionic dispersing agent may be a polyoxyethylene fatty acid or polyoxyethylene alcohol. Again, such compounds are known in the art and can be prepared by the alkoxylation of fatty acids, alcohols or alkylphenols having from 9 to 24 carbon atoms, more preferably from 12 to 22 carbon atoms, in particular from 14 to 20 carbon atoms. The alkoxylation is preferably carried out using ethylene oxide. The aliphatic moieties of the fatty acids and alcohols may be straight chained or branched chain. Particularly preferred compounds of this class are alkylethoxylates, alkylarylethoxylates and alkyloxyethoxylates, for example
available from Clariant GmbH, and
available from Clariant GmbH.
Suitable anionic dispersing agents for use in the formulations are known in the art and are commercially available. The anionic dispersing agent is preferably a sulfonate, sulphate or phosphate of ammonia, an alkali metal or alkaline earth metal, in particular an alkylnaphthalene sulfonic acid formaldehyde condensate, tristyrylphenols or distyrylphenols. Such compounds are available commercially, for example
D425, available from Akzo-Nobel, and
available from Rhodia Chemical Company.
Thickening agents include, but are not limited to, guar gum, pectin, casein, carrageenan, xanthan gum, alginates, methylcellulose, hydroxyethylcellulose, hydroxypropylcellulose, and carboxymethylcellulose, and mixtures thereof. Synthetic thickening agents include derivatives of the former categories, and also polyvinyl alcohols, polyacrylamides, polyvinylpyrrolidones, various polyethers, their copolymers, as well as polyacrylic acids and their salts, and mixtures thereof. Alkylpolyvinylpyrrolidones are particularly useful for the composition of the invention.
Anti-freezing agents are known in the art and are commercially available. Suitable anti-freezing agents include urea, glycerine, liquid polyols, for example ethylene glycol, propylene glycol or glycerol. The amount of anti-freezing agents is generally from about 1% to about 20% by weight, in particular from about 5 to about 10%by weight, based on the total weight of the composition.
Biocides may also be added to the composition according to the invention. Suitable Biocides include those based on isothiazolones, for example
from LONZA Inc. or
RS from Thor Chemie or
MK from Rohm & Haas. The amount of biocides is typically from 0.01% to 0.04% by weight, based on the total weight of composition.
Other formulation components can also be used in the present invention such as dyes, drying agents, and the like. These components and their uses are known to one skilled in the art.
The present invention further provides a method for preventing, treating and/or controlling fungal infestation of a plant, comprising applying to the plant, plant parts, or the surroundings of the plant, a fungicidally effective amount of crystalline modification I of metrafenone as hereinbefore described, or a composition as hereinbefore described.
In a still further aspect, the present invention provides the use of the crystalline modification I of metrafenone as hereinbefore described, or a composition as hereinbefore described, for preventing, treating and/or controlling fungal infestations in plants and/or plant parts.
The crystalline modification I of metrafenone can be employed with other active compounds, such as insecticides, attractants, sterilizing agents, bactericides, acaricides, nematicides, fungicides, growth-regulating substances, herbicides, safeners, fertilizers and semiochemicals, or with agents for improving plant properties. Such other compounds and agents may be included in the same composition as the crystalline modification I of metrafenone or employed in the form of one or more separate compositions.
Preferred mixing partners of the crystalline modification I of metrafenone can be epoxiconazole, fenpropimorph, pyraclostrobin, picoxystrobin, prothioconazole, cyproconazole, azoxystrobin, tebuconazole, difenoconazole, boscalid, dimethomorph, chlorothalonil, bromuconazole, diniconazole, epoxiconazole, fenbuconazole, fuquinconazole, fusilazole, hexaconazole, prochloraz, propiconazole, tetraconazole, trifumizol, futriafol, myclobutanil, kresomix-methyl, dimoxystrobin, benomyl, carbendazim, debacarb, fuberidazole, thiabendazole, thiophanate-methyl, benalaxyl, ofurace, metalaxyl, furalaxyl oxadixyl and their mixtures.
Particular preferred mixing partners are epoxiconazole and the combination of epoxiconazole and fenpropimorph.
All plants and plant parts may be treated with the crystalline modification I of metrafenone in accordance with the present invention. In the present context, plants are to be understood as meaning all plants and plant populations such as desired and undesired wild plants or crop plants, including naturally occurring crop plants. Crop plants may be plants which can be obtained by conventional breeding and optimization methods, by biotechnological and genetic engineering methods, or by combinations of these methods, including the transgenic plants and the plant cultivars which can or cannot be protected by plant breeders' rights. Plant parts are to be understood as meaning all parts and organs of plants above and below the ground, such as shoots, leaves, needles, stalks, stems, flowers, fruit bodies, fruits, seeds, roots, tubers and rhizomes. Harvested materials, and vegetative and generative propagation materials, for example, cuttings, tubers, meristem tissue, rhizomes, offsets, seeds, single and multiple plant cells and any other plant tissues, are also considered as being plant parts.
Throughout the description and claims of this specification, the words “comprise” and variations of the words, for example “comprising” and “comprises” , mean “including but not limited to” , and do not exclude other moieties, additives, components, integers or steps. Moreover the singular encompasses the plural unless the context otherwise requires: in particular, where the indefinite article is used, the specification is to be understood as contemplating plurality as well as singularity, unless the context requires otherwise.
Preferred features of each aspect of the invention may be as described in connection with any of the other aspects. Other features of the invention will become apparent from the following examples. Generally speaking the invention extends to any novel one, or any novel combination, of the features disclosed in this specification, including any accompanying claims and drawings. Thus features, integers, characteristics, compounds, chemical moieties or groups described in conjunction with a particular aspect, embodiment or example of the invention are to be understood to be applicable to any other aspect, embodiment or example described herein unless incompatible therewith. Moreover unless stated otherwise, any feature disclosed herein may be replaced by an alternative feature serving the same or a similar purpose.
Where upper and lower limits are quoted for a property then a range of values defined by a combination of any of the upper limits with any of the lower limits may also be implied.
In this specification, references to properties are, unless stated otherwise, to properties measured under ambient conditions, that is at atmospheric pressure and at a temperature of about 20℃.
As used herein, the term “about” or "around" when used in connection with a numerical amount or range, means somewhat more or somewhat less than the stated numerical amount or range, and for example to a deviation of ± 10% of the stated numerical amount or endpoint of the range.
“Surrounding” as used herein, refers to the place on which the plants are growing, the place on which the plant propagation materials of the plants are sown or the place on which the plant propagation materials of the plants will be sown.
Treatment according to the invention of the plants and plant parts with the compositions or formulations of the invention may be carried out directly or by allowing the compositions or formulations to act on their surroundings, habitat or storage space by the customary treatment methods. Examples of these customary treatment methods include dipping, spraying, vaporizing, fogging, broadcasting, painting on in the case of propagation material, and applying one or more coats particularly in the case of seeds.
Metrafenone, which is an active ingredient of the fungicidal composition of the invention, is known to be effective against a range of fungi, such as powdery mildew.
The benefits of the present invention are seen most when the fungicidal composition is applied to prevent, treat and control fungal infestation in growing crops of useful plants, such as grapes, potatoes, tomatoes, barley, oats, peaches, pumpkins, roses, rye, wheat and other Solanaceae, cucurbits, leafy and fruiting vegetables, bulb vegetables, brassicas, hops and ornamentals.
As discussed hereinbefore, the crystalline modification I of metrafenone prepared using a solvent system comprising an aromatic hydrocarbon and/or an ether exhibits a significantly reduced half-life, in particular under aerobic conditions normally prevailing in soil in the field, leading to a significant reduction in metrafenone residues remaining in the soil after application.
Therefore, in a further aspect, the present invention provides the use of a solvent system comprising a solvent selected from aromatic hydrocarbons, ethers and mixtures thereof to produce a crystalline form of metrafenone having a significantly reduced half-life.
In particular, under aerobic conditions in soil at ambient conditions, the half-life of metrafenone can be reduced from 120 days to between 7 to 14 days, more preferably from 10 to 11 days. In this respect, the half-life of the metrafenone prepared by crystallization from the aforementioned solvent system may be reduced by 90 to 95%.
The present invention provides in a still further aspect, the use of a solvent system comprising a solvent selected from aromatic hydrocarbons, ethers and mixtures thereof to produce a crystalline form of metrafenone exhibiting reduced residues in soil.
Suitable and preferred solvents are discussed hereinbefore.
BRIEF DESCRIPTION OF DRAWINGS
Various features and aspects of the embodiments of the invention disclosed herein can be more clearly understood by reference to the accompanying drawings, which are intended to exemplify and illustrate, but not to limit, the scope of the invention, and wherein:
Figure 1 is an X-ray powder diffractogram (X-RPD) of a crystalline modification I of metrafenone;
Figure 2 is an infrared (IR) spectrum of a crystalline modification I of metrafenone;
Figure 3 is a differential scanning calorimetry (DSC) thermogram of a crystalline modification I of metrafenone; and
Figure 4 is an X-ray powder diffraction spectrum (X-RPD) of an amorphous metrafenone.
The present invention will now be described by way of the following examples, and in which the following measurement techniques have been employed, and which the examples are provided for illustrative purposes only, and not intended to limit the scope of the disclosure.
All percentages are given in weight % unless otherwise indicated.
References herein to ‘room temperature’ are to a temperature in the range of from 20 to 25℃.
All X-ray powder diffractograms were determined using a powder diffractometer in reflection geometry at 25℃, using the following acquisition parameters:
X’Pert Pro MPD from PANalytical B.V. |
Theta compensating slit and graphite monochromator |
Copper (K-alpha) radiation, 40 kV, 40 mA |
Step size: 0.03 degree 2-theta |
Count time: 1.0 second |
Maximum peak intensity: 1705 counts per second |
Scan range: 3-60 degrees 2-theta |
The IR spectrum was measured with the resolution of 4 cm
-1 and with the number of scans being 16 for the crystallized samples. The crystalline modification I of metrafenone can be identified by its characteristic functional group vibration peaks at wavenumbers (cm
-1, ± 0.2%) of one or more of 3386, 3259, 3133, 1660, 1635, 1574, 1527, 1503, 1461, 1436, 1383, 1343, 1300, 1265, 1202, 1077, 1061, 1041, 1028, 928, 762, 639 and 562 cm
-1 as shown in Figure 2.
All IR spectra were obtained using the following acquisition parameters:
FT-IR spectrometer | Nicolet TM iS 5 |
Diamond ATR unit | Thermo Scientific TM iD5 ATR |
Wavelength range | 550-4000 cm -1 |
Resolution | 4 cm -1 |
Number of scans | 16 |
All DSC thermograms were obtained using the following acquisition parameters:
EXAMPLES
Example 1: Preparation of crystalline metrafenone in accordance with the disclosure of EP 0897904 (Example 6C)
A mixture of 5-Bromo-6-methyl-2-methoxybenzoic acid (24 g, 10 mmol) , 3, 4, 5-trimethoxytoluene (1.82 g; 10 mmol) , P
2O
5 (10.0 g) and dichloromethane (150 mL) was stirred at room temperature for 16 hours. Subsequently, the dichloromethane was distilled off and the residue was diluted with ethyl acetate. The organic phase was washed with water and concentrated. The residue was purified by column chromatography (petrol ether: ethyl acetate, 8: 2 v/v) and recrystallized from diisopropylether. The solid material was collected by vacuum filtration, washed with cold petrol ethers: diisopropylether (1: 1 v/v) and dried, yielding white solid (2.2 g, 54%) , having a melting point 89 to 91℃.
The reaction sequence may be illustrated as follows:
As shown in Figure 4, the X-ray powder diffraction pattern of the resulting metrafenone product has no significant signals, which indicates the metrafenone product prepared in accordance with the disclosure of EP 0897904 is amorphous.
Example 2: Preparation of the crystalline modification I of metrafenone from xylene
Example 1 was repeated a few times and the solid metrafenone obtained was combined. 4 g of the metrafenone from Example 1 was placed in a 3-neck round bottom flask along with 25 mL of xylene and the resulting slurry was heated to 65℃ to get a homogeneous solution. The insoluble particles, if any, were removed by filtration and the solution was slowly cooled to ambient temperature. Fine crystals were formed during the cooling and the mixture was stirred at ambient temperature for 2 hours.
Thereafter, the slurry was filtered and washed with 3 mL of cooled xylene. The filtered crystals were dried under vacuum at 40℃ in order to remove the xylene traces from the crystalline product. The crystalline product thus obtained had a purity of 98%and the yield was found to be about 90%.
The crystals were analyzed by X-RPD, IR spectrometry and DSC and found to be a crystalline modification I of metrafenone having the characteristics shown in Figure 1, Figure 2 and Figure 3 respectively.
The IR spectrum of the crystalline metrafenone exhibited the functional group characteristic vibration peaks at wavenumbers of one or more of 3386, 3259, 3133, 1660, 1635, 1574, 1527, 1503, 1461, 1436, 1383, 1343, 1300, 1265, 1202, 1077, 1061, 1041, 1028, 928, 762, 639 and 562 cm
-1 as shown in Figure 2.
The DSC thermogram of the crystalline metrafenone exhibited an endothermic melting peak maximum at 99.5℃ as shown in Figure 3.
The X-ray powder diffractogram of the metrafenone crystals exhibited the reflexes in Figure 1 and the values are summarized in Table 1 below.
Table 1
Example 3: Preparation of the crystalline modification I of metrafenone from methyl t-butyl ether
4 g of the metrafenone sample prepared in Example 1 was placed in a 3-neck round bottom flask along with 30 mL of methyl t-butyl ether and the resulting slurry was heated to 40℃ to get a homogeneous solution. The insoluble particles, if any, were removed by filtration and the solution was slowly cooled to ambient temperature. Fine crystals were formed during the cooling and the mixture was stirred at ambient temperature for 2 hours.
Thereafter, the slurry was filtered, washed with 3 mL of methyl t-butyl ether. The filtered crystals were dried under vacuum at 40℃ in order to remove the methyl t-butyl ether traces from the crystalline product.
The crystalline product thus obtained had a purity of 98% and the yield was found to be about 88%. The crystalline modification I of metrafenone was obtained, as determined using X-RPD, IR spectrometry and DSC analysis.
Example 4: Preparation of suspension concentrate (SC)
Samples were prepared by mixing all the components listed in Table 2 uniformly and grinding with a Dyno-Mill (manufactured by Willy A. Bachofen AG) to obtain a suspension concentrate.
Table 2
Compositions S2 and S3 contain the crystalline modification I of metrafenone and are embodiments of the present invention. Composition S1 is a comparative example.
Example 5: Residue Test in Soil
A 140g soil sample was collected from the field and divided into 14 different pots (6cm diameter plastic pots) . The metrafenone product obtained in Examples 1 to 3 and the compositions S1, S2 and S3 prepared in Example 4 were each added to the soil in two pots, to provide two replications, in an amount such that the final concentration of metrafenone in the soil in the pots was 50ppm.
In addition, metrafenone prepared by recrystallization from a solvent system of 15% wt ethyl acetate in heptane was also added to the soil in one pot, to provide a further comparison.
Untreated soil was used as a control.
All the pots were maintained in a greenhouse at an ambient temperature of about 20℃. The soil in the pots had a humidity of about 60%.
The amount of metrafenone remaining in the soil in each pot was determined at regular intervals after treatment, as follows:
1 g of soil sample was collected from each pot and added to a 10mL centrifuge tube. Deionized water (1mL) and acetonitrile (2mL) were added and mixture subjected to mixing for 3 minutes. Thereafter, sodium chloride (1 g) was added and the resulting mixture subjected to mixing for a further 5 minutes. Finally, the tube was centrifuged at 4000rpm for 5 minutes.
The supernatant was collected and filtered through a 0.2 m membrane for analysis using chromatography, as follows.
All the samples were analyzed using UPLC-MS/MS, under the following conditions:
Mobile phase was acetonitrile and deionized water with 0.2% Formic acid;
Flow: 0.3mL/min;
Inject Volume: 5 L;
Column: Waters Acquity UPLC HSS T3 having internal diameter of 2.1mm, 100mm length, and 1.8 m particle size;
Column temperature was 35℃.
The retention time of metrafenone in the column is 2.87 minutes.
Gradient of mobile phase:
TIME (minute) | Acetonitrile | H 2O (0.2% HCOOH) |
0 | 10 | 90 |
1.5 | 90 | 10 |
3 | 90 | 10 |
3.1 | 10 | 90 |
4 | 10 | 90 |
50.01 | STOP |
The results are set out in Table 3 below.Table 3
As can be seen from the data in Table 3, metrafenone prepared according to the known method of the prior art (Example 1) and present in the suspension concentrate containing the same (S1) remained in the soil in significant amounts after 7 days, with significant amounts still remaining after 130 days. A similar result was obtained using crystalline metrafenone prepared using ethyl acetate/heptane as the solvent.
In contrast, the crystalline modification I of metrafenone (Examples 2 and 3) and the compositions containing the same (S2 and S3) resulted in a significant reduction in the metrafenone residue present in the soil after just 7 days. The data show that the persistence of the crystalline modification I of metrafenone is significantly reduced, compared with the metrafenone product of the prior art.
It is to be noted that the metrafenone product of the prior art exhibited a half-life in the soil of about 120 days. In contrast, the crystalline modification I of metrafenone according to the present invention exhibited a significantly reduced half-life in the soil, in particular between 7 and 14 days, more particularly from 10 to 11 days.
Claims (25)
- A crystalline modification I of (3-bromo-6-methoxy-2-methylphenyl) (2, 3, 4-trimethoxy-6-methylphenyl) methanone (metrafenone) exhibiting at least 3 of the following reflexes, in any combination, as 2θ ± 0.2 degree in an X-ray powder diffractogram (X-RPD) recorded using Cu-Kα radiation at 25℃:2θ = 8.6 ± 0.2 (1)2θ = 10.0 ± 0.2 (2)2θ = 10.6 ± 0.2 (3)2θ = 11.5 ± 0.2 (4)2θ = 12.2 ± 0.2 (5)2θ = 15.6 ± 0.2 (6)2θ = 17.3 ± 0.2 (7)2θ = 20.5 ± 0.2 (8)2θ = 21.7 ± 0.2 (9)2θ = 22.6 ± 0.2 (10)2θ = 25.0 ± 0.2 (11)2θ = 25.6 ± 0.2 (12)2θ = 25.7 ± 0.2 (13)2θ = 27.3 ± 0.2 (14)2θ = 28.4 ± 0.2 (15)2θ = 28.9 ± 0.2 (16)2θ = 32.1 ± 0.2 (17) .
- The crystalline modification I of metrafenone according to claim 1, exhibiting at least 3, more preferably 4, 5, 6, 7, 8, 9, 10, 11 or more, still more preferably all, of the reflexes, in any combination from the following:2θ = 8.6 ± 0.2 (1)2θ = 10.0 ± 0.2 (2)2θ = 10.6 ± 0.2 (3)2θ = 11.5 ± 0.2 (4)2θ = 12.2 ± 0.2 (5)2θ = 15.6 ± 0.2 (6)2θ = 17.3 ± 0.2 (7)2θ = 20.5 ± 0.2 (8)2θ = 21.7 ± 0.2 (9)2θ = 22.6 ± 0.2 (10)2θ = 25.0 ± 0.2 (11)2θ = 27.3 ± 0.2 (14)2θ = 32.1 ± 0.2 (17) .
- The crystalline modification I of metrafenone according to claim 1 or 2, characterized by an X-ray powder diffraction pattern substantially as shown in Figure 1.
- A crystalline modification I of metrafenone exhibiting an IR spectrum with characteristic functional group vibration peaks at wavenumbers (cm -1, ± 0.2%) of one or more of 3386, 3259, 3133, 1660, 1635, 1574, 1527, 1503, 1461, 1436, 1383, 1343, 1300, 1265, 1202, 1077, 1061, 1041, 1028, 928, 762, 639 and 562 cm -1.
- The crystalline modification I of metrafenone according to claim 4, characterized by an IR spectrum substantially as shown in Figure 2.
- A crystalline modification I of metrafenone exhibiting a differential scanning calorimetry (DSC) profile having an endothermic melting peak with onset at 97.7 ℃ and peak maximum at 99.5 ℃.
- The crystalline modification I of metrafenone according to claim 6, characterized by a DSC thermogram substantially as shown in Figure 3.
- The crystalline modification I of metrafenone according to any one of claims 1 to 3, further exhibiting an IR spectrum according to either of claims 4 or 5 and/or a differential scanning calorimetry (DSC) profile according to either of claims 6 or 7.
- A method for the preparation of a crystalline modification I of metrafenone according to any one of claims 1 to 8, the method comprising:i) dissolving metrafenone in a solvent system comprising one or more solvents;ii) precipitating the dissolved metrafenone from solution in the solvent system to yield the crystalline modification I of metrafenone; andiii) isolating the precipitated crystalline modification I.
- The method according to claim 9, wherein the metrafenone in step i) is a crystalline modification of metrafenone other than the crystalline modification I of metrafenone.
- The method according to claim 9 or 10, wherein the solvent system comprises a solvent selected from aromatic hydrocarbons, ethers and mixtures thereof.
- The method according to any one of claims 9 to 11, wherein the solvent system comprises an ether of the general formula R – O – R 1, wherein R and R 1 each independently represent a lower alkyl group.
- The method according to claim11 or 12, wherein the solvent system comprises xylene and/or methyl t-butyl ether.
- The method according to any one of claims 9 to 13, wherein step ii) comprises concentrating the solution by removal of solvent and/or cooling the solvent system.
- The method according to any one of claims 9 to 14, wherein in step ii) seed crystals are added to the solution formed in step i) .
- The method according to claim 15, wherein the seed crystals comprise the crystalline modification I of metrafenone.
- A crystalline material comprising the crystalline modification I of metrafenone produced by the method according to any one of claims 9 to 16.
- A composition comprising the crystalline modification I of metrafenone according to any one of claims 1 to 8 or the crystalline material according to claim 17 and at least one auxiliary.
- The composition according to claim 18, wherein the auxiliary is selected from surfactants, dispersants, wetting agents, emulsifiers, extenders, carriers, solvents, surfactants, stabilizers, anti-foam agents, anti-freezing agents, preservatives, antioxidants, colourants, thickeners, biocides, solid adherents, inert fillers, and mixtures thereof.
- The composition according to claim 18 or 19, wherein the composition is in the form of a suspension concentrate (SC) , an oil dispersion (OD) , water-soluble granules (SG) , a dispersible concentrate (DC) , an emulsifiable concentrate (EC) , an emulsion seed dressing, a suspension seed dressing, granules (GR) , microgranules (MG) , a suspoemulsion (SE) or water-dispersible granules (WG) .
- The composition according to claim 20, wherein the composition is in the form of a suspension concentrate (SC) .
- A method for preventing, treating and/or controlling fungal infestation of a plant, comprising applying to the plant, plant parts, or the surroundings of the plant, a fungicidally effective amount of the crystalline modification I of metrafenone according to any one of claims 1 to 8 or the crystalline material according to claim 17, or the composition according to any one of claims 18 to 21.
- Use of the crystalline modification I of metrafenone according to any one of claims 1 to 8 or the crystalline material according to claim 17 for preventing, treating and/or controlling fungal infestation in a plant or plant parts.
- Use of a solvent system comprising a solvent selected from aromatic hydrocarbons, ethers and mixtures thereof to produce a crystalline form of metrafenone having a significantly reduced half-life.
- Use of a solvent system comprising a solvent selected from aromatic hydrocarbons, ethers and mixtures thereof to produce a crystalline form of metrafenone exhibiting reduced residues in soil.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP21764047.3A EP4114817A4 (en) | 2020-03-06 | 2021-01-20 | A novel form of metrafenone, a process for its preparation and use of the same |
CN202180018590.9A CN115244027A (en) | 2020-03-06 | 2021-01-20 | Novel forms of metrafenone, process for their preparation and their use |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB2003282.7 | 2020-03-06 | ||
GB2003282.7A GB2592668B (en) | 2020-03-06 | 2020-03-06 | A novel form of metrafenone, a process for its preparation and use of the same |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2021175029A1 true WO2021175029A1 (en) | 2021-09-10 |
Family
ID=70278448
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/CN2021/072802 WO2021175029A1 (en) | 2020-03-06 | 2021-01-20 | A novel form of metrafenone, a process for its preparation and use of the same |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP4114817A4 (en) |
CN (1) | CN115244027A (en) |
GB (1) | GB2592668B (en) |
WO (1) | WO2021175029A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1217317A (en) * | 1997-08-20 | 1999-05-26 | 美国氰胺公司 | Fungus-killing compound of 2-methoxydiphenylketones |
US20010031753A1 (en) * | 2000-01-13 | 2001-10-18 | Basf Corporation | Process for the preparation of substituted benzophenones |
CN1726178A (en) * | 2002-12-13 | 2006-01-25 | 巴斯福股份公司 | Method for the production of benzophenonen |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE69803907T2 (en) * | 1997-08-20 | 2002-06-27 | Basf Ag | Fungicides 2-methoxybenzophenones |
ES2374856T3 (en) * | 2007-07-06 | 2012-02-22 | Basf Se | CRYSTAL FORM OF [3- (4,5-DIHIDRO-3-ISOXALIL) -2-METHYL-4- (METILSULFONIL) PHENYL] - (5-HYDROXI-1-METHYL-1H-PIRAZOL-4-IL) METANONE. |
-
2020
- 2020-03-06 GB GB2003282.7A patent/GB2592668B/en active Active
-
2021
- 2021-01-20 WO PCT/CN2021/072802 patent/WO2021175029A1/en unknown
- 2021-01-20 CN CN202180018590.9A patent/CN115244027A/en active Pending
- 2021-01-20 EP EP21764047.3A patent/EP4114817A4/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1217317A (en) * | 1997-08-20 | 1999-05-26 | 美国氰胺公司 | Fungus-killing compound of 2-methoxydiphenylketones |
US20010031753A1 (en) * | 2000-01-13 | 2001-10-18 | Basf Corporation | Process for the preparation of substituted benzophenones |
CN1726178A (en) * | 2002-12-13 | 2006-01-25 | 巴斯福股份公司 | Method for the production of benzophenonen |
Non-Patent Citations (2)
Title |
---|
CHEN,YIFEN: " Synthesis of Metrafenone", CHINESE JOURNAL OF SYNTHETIC CHEMISTRY, CHENGDU YUJI HUAXUESUO, CN, vol. 17, no. 3, 20 June 2009 (2009-06-20), CN, pages 390 - 391, XP055842810, ISSN: 1005-1511 * |
See also references of EP4114817A4 * |
Also Published As
Publication number | Publication date |
---|---|
EP4114817A1 (en) | 2023-01-11 |
GB202003282D0 (en) | 2020-04-22 |
GB2592668B (en) | 2024-08-14 |
EP4114817A4 (en) | 2024-03-27 |
GB2592668A (en) | 2021-09-08 |
CN115244027A (en) | 2022-10-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU2021427503B2 (en) | Novel crystalline form of pyroxasulfone, methods for its preparation and use of the same | |
US10005754B2 (en) | Form of spirodiclofen, a process for its preparation and use the same | |
WO2017197909A1 (en) | Novel form of sulfentrazone, process for its preparation and use thereof | |
WO2018188356A1 (en) | Crystalline form of spirotetramat, process for preparation and use thereof | |
WO2021115494A1 (en) | Novel crystalline forms of flufenacet, methods for their preparation and use of the same | |
WO2018137387A1 (en) | Crystalline form of indoxacarb, process for its preparation and use thereof | |
WO2021175029A1 (en) | A novel form of metrafenone, a process for its preparation and use of the same | |
AU2016102018A4 (en) | A novel crystalline form of chlorfenapyr, a process for its preparation and use of the same | |
WO2021115493A2 (en) | Novel crystalline forms of flufenacet, methods for their preparation and use of the same | |
WO2017092469A1 (en) | Novel crystalline form of tribenuron-methyl, process for preparation and use thereof | |
US11602148B2 (en) | Crystalline form of oxamyl process for its preparation and use of the same | |
AU2017232185B2 (en) | A novel crystalline form of cyflufenamid, a process for its preparation and use of the same | |
WO2020164287A1 (en) | A novel form of metconazole, a process for its preparation and use of the same | |
WO2023040759A1 (en) | Crystalline form of methoxyfenozide, process for its preparation and use of the same | |
US10077248B2 (en) | Form of imazapyr, a process for its preparation and use the same | |
WO2020042052A1 (en) | A novel form of sulfometuron methyl, a process for its preparation and use the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21764047 Country of ref document: EP Kind code of ref document: A1 |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2021764047 Country of ref document: EP Effective date: 20221006 |